GENWORTH FINANCIAL INC (GNW) FY 2024 MD&A
This page reproduces the company's own Item 7 MD&A text from the linked SEC filing. It is filer text, not grepcent analysis, scoring, or investment advice.
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations
The following discussion and analysis of our consolidated financial condition and results of operations should be read in conjunction with our audited consolidated financial statements and related notes included in “Item 8—Financial Statements and Supplementary Data.”
68
Table of Contents
Item 7 of our Annual Report on Form 10-K generally discusses year-to-year comparisons between the years ended December 31, 2024 and 2023. Discussions of information related to 2022 and year-to-year comparisons between 2023 and 2022 are not included in this Form 10-K. Comparative discussions between 2023 and 2022 can be found in “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended December 31, 2023.
Overview
Our business
Genworth Financial, through its principal insurance subsidiaries, offers mortgage and long-term care insurance products. Genworth Financial is the parent company of Enact Holdings, a leading provider of private mortgage insurance in the United States through its mortgage insurance subsidiaries. Genworth Financial’s U.S. life insurance subsidiaries offer long-term care insurance and also manage in-force blocks of life insurance and annuity products which are no longer sold. We report our business results through three segments: Enact; Long-Term Care Insurance; and Life and Annuities. In addition to our three segments, we report certain of our results of operations in Corporate and Other.
Our financial information
The financial information in this Annual Report on Form 10-K has been derived from our consolidated financial statements.
Revenues and expenses
Our revenues consist primarily of the following:
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Premiums. Premiums consist primarily of premiums earned on insurance products for mortgage, long-term care and term life insurance. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Net investment income. Net investment income represents the income earned on our investments. For discussion of the change in net investment income, see the comparison for this line item under “—Investments and Derivative Instruments.” |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Net investment gains (losses). Net investment gains (losses) consist primarily of realized gains and losses from the sale of our investments, credit losses, and unrealized gains and losses on equity securities, limited partnership investments and derivative instruments. For discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.” |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Policy fees and other income. Policy fees and other income consists primarily of fees assessed against policyholder and contractholder account values, surrender charges, cost of insurance assessed on universal and term universal life insurance policies, advisory and administration service fees assessed on investment contractholder account values, broker-dealer commission revenues, fee revenue from contract underwriting services and other fees. |
Our expenses consist primarily of the following:
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Benefits and other changes in policy reserves. Benefits and other changes in policy reserves consist primarily of benefits paid, interest accretion expense, and other reserve activity related to future policy benefits for long-term care insurance, life insurance, and fixed and variable annuities, and claim costs incurred related to mortgage insurance products. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Liability remeasurement (gains) losses. Liability remeasurement (gains) losses represent changes to the net premium ratio for actual variances from expected experience and updates to cash flow assumptions used to measure long-duration traditional and limited-payment insurance contracts. |
69
Table of Contents
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Changes in fair value of market risk benefits and associated hedges. Changes in fair value of market risk benefits and associated hedges consist of fair value changes of market risk benefits (other than changes attributable to instrument-specific credit risk), net of changes in the fair value of non-qualified derivative instruments that support our market risk benefits. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Interest credited. Interest credited represents interest credited on behalf of policyholder and contractholder general account balances. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Acquisition and operating expenses, net of deferrals. Acquisition and operating expenses, net of deferrals, represent costs and expenses related to the acquisition and ongoing maintenance of insurance and investment contracts, including commissions, policy issuance expenses and other underwriting and general operating costs. These costs and expenses are net of amounts that are capitalized and deferred, which are costs and expenses that are related directly to the successful acquisition of new or renewal insurance policies and investment contracts, such as first-year commissions in excess of ultimate renewal commissions and other policy issuance expenses. We allocate certain corporate expenses to each of our segments using various methodologies. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Amortization of deferred acquisition costs and intangibles. Amortization of deferred acquisition costs (“DAC”) and intangibles consists primarily of the amortization of capitalized acquisition costs, present value of future profits and capitalized software. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Interest expense. Interest expense primarily represents interest incurred on borrowings of Genworth Holdings and Enact Holdings. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Provision (benefit) for income taxes. We allocate tax to our businesses at the U.S. corporate federal income tax rate of 21%. Each segment is then adjusted to reflect the unique tax attributes of that segment, such as permanent differences between U.S. GAAP and tax law. The difference between the consolidated provision for income taxes and the sum of the provision for income taxes in each segment is reflected in Corporate and Other. |
The effective tax rates disclosed herein are calculated using whole numbers. As a result, the percentages shown may differ from an effective tax rate calculated using rounded numbers.
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Net income attributable to noncontrolling interests. Net income attributable to noncontrolling interests represents third-party ownership interests in income of Enact Holdings, a consolidated subsidiary of Genworth Financial. |
70
Table of Contents
Consolidated Results of Operations
The following table sets forth the consolidated results of operations for the periods indicated:
| Increase (decrease) and | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Years ended December 31, | percentage change | |||||||||||||||||||||||||||
| (Amounts in millions) | 2024 | 2023 | 2022 | 2024 vs. 2023 | 2023 vs. 2022 | |||||||||||||||||||||||
| Revenues: | ||||||||||||||||||||||||||||
| Premiums | $ | 3,480 | $ | 3,636 | $ | 3,680 | $ | (156 | ) | (4 | )% | $ | (44 | ) | (1 | )% | ||||||||||||
| Net investment income | 3,160 | 3,183 | 3,146 | (23 | ) | (1 | )% | 37 | 1 | % | ||||||||||||||||||
| Net investment gains (losses) | 13 | 23 | (2 | ) | (10 | ) | (43 | )% | 25 | NM | (1) | |||||||||||||||||
| Policy fees and other income | 642 | 646 | 671 | (4 | ) | (1 | )% | (25 | ) | (4 | )% | |||||||||||||||||
| Total revenues | 7,295 | 7,488 | 7,495 | (193 | ) | (3 | )% | (7 | ) | — | % | |||||||||||||||||
| Benefits and expenses: | ||||||||||||||||||||||||||||
| Benefits and other changes in policy reserves | 4,766 | 4,783 | 4,303 | (17 | ) | — | % | 480 | 11 | % | ||||||||||||||||||
| Liability remeasurement (gains) losses | 153 | 587 | (290 | ) | (434 | ) | (74 | )% | 877 | NM | (1) | |||||||||||||||||
| Changes in fair value of market risk benefits and associated hedges | (13 | ) | (12 | ) | (104 | ) | (1 | ) | (8 | )% | 92 | 88 | % | |||||||||||||||
| Interest credited | 453 | 503 | 504 | (50 | ) | (10 | )% | (1 | ) | — | % | |||||||||||||||||
| Acquisition and operating expenses, net of deferrals | 977 | 942 | 1,285 | 35 | 4 | % | (343 | ) | (27 | )% | ||||||||||||||||||
| Amortization of deferred acquisition costs and intangibles | 249 | 264 | 326 | (15 | ) | (6 | )% | (62 | ) | (19 | )% | |||||||||||||||||
| Interest expense | 115 | 118 | 106 | (3 | ) | (3 | )% | 12 | 11 | % | ||||||||||||||||||
| Total benefits and expenses | 6,700 | 7,185 | 6,130 | (485 | ) | (7 | )% | 1,055 | 17 | % | ||||||||||||||||||
| Income from continuing operations before income taxes | 595 | 303 | 1,365 | 292 | 96 | % | (1,062 | ) | (78 | )% | ||||||||||||||||||
| Provision for income taxes | 158 | 104 | 319 | 54 | 52 | % | (215 | ) | (67 | )% | ||||||||||||||||||
| Income from continuing operations | 437 | 199 | 1,046 | 238 | 120 | % | (847 | ) | (81 | )% | ||||||||||||||||||
| Loss from discontinued operations, net of taxes | (10 | ) | — | — | (10 | ) | NM | (1) | — | — | % | |||||||||||||||||
| Net income | 427 | 199 | 1,046 | 228 | 115 | % | (847 | ) | (81 | )% | ||||||||||||||||||
| Less: net income attributable to noncontrolling interests | 128 | 123 | 130 | 5 | 4 | % | (7 | ) | (5 | )% | ||||||||||||||||||
| Net income available to Genworth Financial, Inc.’s common stockholders | $ | 299 | $ | 76 | $ | 916 | $ | 223 | NM | (1) | $ | (840 | ) | (92 | )% |
| Column 1 | Column 2 |
|---|---|
| (1) | We define “NM” as not meaningful for increases or decreases greater than 200%. |
Unless otherwise stated, all references to net income (loss), net income (loss) per share, adjusted operating income (loss) and adjusted operating income (loss) per share found in “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations” should be read as net income (loss) available to Genworth Financial, Inc.’s common stockholders, net income (loss) available to Genworth Financial, Inc.’s common stockholders per share, adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders and adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders per share, respectively.
Use of non-GAAP measures
Reconciliation of net income (loss) to adjusted operating income (loss)
Our chief operating decision maker (“CODM”) evaluates performance and allocates resources based on a non-GAAP financial measure entitled “adjusted operating income (loss).” Our CODM evaluates adjusted
71
Table of Contents
operating income (loss) as a key measure to assess performance and support new business initiatives because the measure more accurately reflects overall operating performance, as it minimizes the impact of macroeconomic volatility. Our legacy U.S. life insurance subsidiaries, which comprise our Long-Term Care Insurance and Life and Annuities segments, are managed on a standalone basis; therefore, we do not allocate capital to our Long-Term Care Insurance and Life and Annuities segments.
We define adjusted operating income (loss) as income (loss) from continuing operations excluding the after-tax effects of income (loss) attributable to noncontrolling interests, net investment gains (losses), changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items. A component of our net investment gains (losses) is the result of estimated future credit losses, the size and timing of which can vary significantly depending on market credit cycles. In addition, the size and timing of other investment gains (losses) can be subject to our discretion and are influenced by market opportunities, as well as asset-liability matching considerations. We exclude net investment gains (losses), changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, restructuring costs and infrequent or unusual non-operating items from adjusted operating income (loss) because, in our opinion, they are not indicative of overall operating performance.
While some of these items may be significant components of net income (loss) determined in accordance with U.S. GAAP, we believe that adjusted operating income (loss), and measures that are derived from or incorporate adjusted operating income (loss), are appropriate measures that are useful to investors because they identify the income (loss) attributable to the ongoing operations of the business. Adjusted operating income (loss) is not a substitute for net income (loss) determined in accordance with U.S. GAAP. In addition, our definition of adjusted operating income (loss) may differ from the definitions used by other companies.
Adjustments to reconcile net income (loss) to adjusted operating income (loss) assume a 21% tax rate and are net of the portion attributable to noncontrolling interests. Changes in fair value of market risk benefits and associated hedges are adjusted to exclude changes in reserves, attributed fees and benefit payments.
72
Table of Contents
The following table presents a reconciliation of net income to adjusted operating income for the years ended December 31:
| (Amounts in millions) | 2024 | 2023 | 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income available to Genworth Financial, Inc.’s common stockholders | $ | 299 | $ | 76 | $ | 916 | ||||||
| Add: net income attributable to noncontrolling interests | 128 | 123 | 130 | |||||||||
| Net income | 427 | 199 | 1,046 | |||||||||
| Less: loss from discontinued operations, net of taxes | (10 | ) | — | — | ||||||||
| Income from continuing operations | 437 | 199 | 1,046 | |||||||||
| Less: net income from continuing operations attributable to noncontrolling interests | 128 | 123 | 130 | |||||||||
| Income from continuing operations available to Genworth Financial, Inc.’s common stockholders | 309 | 76 | 916 | |||||||||
| Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders: | ||||||||||||
| Net investment (gains) losses, net (1) | (17 | ) | (25 | ) | 2 | |||||||
| Changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges (2) | (43 | ) | (22 | ) | (142 | ) | ||||||
| (Gains) losses on early extinguishment of debt (3) | 2 | (2 | ) | 6 | ||||||||
| Expenses related to restructuring | 12 | 4 | 2 | |||||||||
| Pension plan termination costs | — | — | 8 | |||||||||
| Taxes on adjustments | 10 | 10 | 26 | |||||||||
| Adjusted operating income available to Genworth Financial, Inc.’s common stockholders | $ | 273 | $ | 41 | $ | 818 |
| Column 1 | Column 2 |
|---|---|
| (1) | For the years ended December 31, 2024 and 2023, net investment (gains) losses were adjusted for the portion attributable to noncontrolling interests of $4 million and $2 million, respectively. |
| Column 1 | Column 2 |
|---|---|
| (2) | Changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments of $(30) million, $(10) million and $(38) million for the years ended December 31, 2024, 2023 and 2022, respectively. |
| Column 1 | Column 2 |
|---|---|
| (3) | (Gains) losses on early extinguishment of debt were net of the portion attributable to noncontrolling interests of $2 million for the year ended December 31, 2024. |
Other than pension plan termination costs incurred in 2022 related to one of our defined benefit pension plans, there were no infrequent or unusual items excluded from adjusted operating income during the periods presented.
73
Table of Contents
Earnings per share
The following table provides basic and diluted earnings per common share for the periods indicated:
| Increase (decrease) and | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Years ended December 31, | percentage change | |||||||||||||||||||||||||||
| (Amounts in millions, except per share amounts) | 2024 | 2023 | 2022 | 2024 vs. 2023 | 2023 vs. 2022 | |||||||||||||||||||||||
| Income from continuing operations available to Genworth Financial, Inc.’s common stockholders per share: | ||||||||||||||||||||||||||||
| Basic | $ | 0.71 | $ | 0.16 | $ | 1.82 | $ | 0.55 | NM | (1) | $ | (1.66 | ) | (91 | )% | |||||||||||||
| Diluted | $ | 0.70 | $ | 0.16 | $ | 1.79 | $ | 0.54 | NM | (1) | $ | (1.63 | ) | (91 | )% | |||||||||||||
| Net income available to Genworth Financial, Inc.’s common stockholders per share: | ||||||||||||||||||||||||||||
| Basic | $ | 0.69 | $ | 0.16 | $ | 1.82 | $ | 0.53 | NM | (1) | $ | (1.66 | ) | (91 | )% | |||||||||||||
| Diluted | $ | 0.68 | $ | 0.16 | $ | 1.79 | $ | 0.52 | NM | (1) | $ | (1.63 | ) | (91 | )% | |||||||||||||
| Adjusted operating income available to Genworth Financial, Inc.’s common stockholders per share: | ||||||||||||||||||||||||||||
| Basic | $ | 0.63 | $ | 0.09 | $ | 1.62 | $ | 0.54 | NM | (1) | $ | (1.53 | ) | (94 | )% | |||||||||||||
| Diluted | $ | 0.62 | $ | 0.09 | $ | 1.60 | $ | 0.53 | NM | (1) | $ | (1.51 | ) | (94 | )% | |||||||||||||
| Weighted-average common shares outstanding: | ||||||||||||||||||||||||||||
| Basic | 433.9 | 468.8 | 504.4 | |||||||||||||||||||||||||
| Diluted | 439.4 | 474.9 | 510.9 |
| Column 1 | Column 2 |
|---|---|
| (1) | We define “NM” as not meaningful for increases or decreases greater than 200%. |
Diluted weighted-average common shares outstanding reflect the effects of potentially dilutive securities including performance stock units, restricted stock units and other equity-based awards.
The following table presents a summary of adjusted operating income (loss) for our segments and Corporate and Other for the periods indicated:
| Increase (decrease) and | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Years ended December 31, | percentage change | |||||||||||||||||||||||||||
| (Amounts in millions) | 2024 | 2023 | 2022 | 2024 vs. 2023 | 2023 vs. 2022 | |||||||||||||||||||||||
| Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders: | ||||||||||||||||||||||||||||
| Enact segment | $ | 585 | $ | 552 | $ | 578 | $ | 33 | 6 | % | $ | (26 | ) | (4 | )% | |||||||||||||
| Long-Term Care Insurance segment | (176 | ) | (242 | ) | 320 | 66 | 27 | % | (562 | ) | (176 | )% | ||||||||||||||||
| Life and Annuities segment: | ||||||||||||||||||||||||||||
| Life insurance | (94 | ) | (275 | ) | (111 | ) | 181 | 66 | % | (164 | ) | (148 | )% | |||||||||||||||
| Fixed annuities | 30 | 50 | 62 | (20 | ) | (40 | )% | (12 | ) | (19 | )% | |||||||||||||||||
| Variable annuities | 26 | 37 | 21 | (11 | ) | (30 | )% | 16 | 76 | % | ||||||||||||||||||
| Life and Annuities segment | (38 | ) | (188 | ) | (28 | ) | 150 | 80 | % | (160 | ) | NM | (1) | |||||||||||||||
| Corporate and Other | (98 | ) | (81 | ) | (52 | ) | (17 | ) | (21 | )% | (29 | ) | (56 | )% | ||||||||||||||
| Adjusted operating income available to Genworth | ||||||||||||||||||||||||||||
| Financial, Inc.’s common stockholders | $ | 273 | $ | 41 | $ | 818 | $ | 232 | NM | (1) | $ | (777 | ) | (95 | )% |
| Column 1 | Column 2 |
|---|---|
| (1) | We define “NM” as not meaningful for increases or decreases greater than 200%. |
74
Table of Contents
Executive Summary of Consolidated Financial Results
Below is an executive summary of our consolidated financial results for the periods indicated. Amounts included within this “Executive Summary of Consolidated Financial Results” are net of taxes, unless otherwise indicated. After-tax amounts assume a tax rate of 21%.
For a discussion of selected financial information and detailed descriptions of operating performance measures see “—Results of Operations and Selected Financial and Operating Performance Measures by Segment.”
2024 compared to 2023
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Net income in 2024 and 2023 was $299 million and $76 million, respectively, and adjusted operating income was $273 million and $41 million, respectively. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Enact segment |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Adjusted operating income increased primarily attributable to higher net investment income and premiums, partially offset by higher new delinquencies in 2024. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Long-Term Care Insurance segment |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | The adjusted operating loss decreased primarily driven by lower liability remeasurement losses, net insurance recoveries and higher income from limited partnerships, partially offset by lower renewal premiums in 2024. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Life and Annuities segment |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Life insurance |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | The adjusted operating loss decreased primarily from liability remeasurement gains in 2024 compared to losses in 2023, partially offset by lower premiums and a less favorable change in reserves in 2024 in our term life insurance products related to block runoff. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Fixed annuities |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Adjusted operating income decreased mainly from unfavorable assumption updates of $9 million primarily related to our fixed indexed annuity lapse assumptions in 2024, as well as lower net spreads primarily related to block runoff. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Variable annuities |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Adjusted operating income decreased largely from an unfavorable lapse assumption update of $5 million in 2024 compared to favorable assumption updates in 2023. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Corporate and Other |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | The adjusted operating loss increased primarily from higher expenses related to CareScout growth initiatives, partially offset by a higher benefit for income taxes in 2024. |
Significant Developments and Strategic Highlights
Enact segment
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Mortgage insurance portfolio. Enact’s primary persistency rate of 83% for the year ended December 31, 2024 decreased from 85% for the year ended December 31, 2023 due to rate volatility throughout 2024. Elevated persistency continued to offset the decline in new insurance written, contributing to primary insurance in-force growth of $5.9 billion in 2024. New insurance written decreased 4% during 2024 compared to 2023. |
75
Table of Contents
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Loss performance. Enact recorded pre-tax reserve releases of $252 million in 2024 primarily related to favorable cure performance and loss mitigation activities compared to pre-tax reserve releases of $241 million in 2023. New primary delinquencies in 2024 increased compared to 2023 largely due to the aging of large, newer books of business. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | PMIERs compliance. Enact’s PMIERs sufficiency ratio was 167% or $2,052 million above the PMIERs requirements as of December 31, 2024. On August 21, 2024, the GSEs and the FHFA released updated PMIERs requirements phasing in a revision to the available assets standards between March 31, 2025 and September 30, 2026. Enact expects to hold capital sufficiency well in excess of these requirements and does not expect the impact of these updates to be material to its sufficiency. For additional details on the updated requirements, see “Item 1—Regulation—Enact—Mortgage Insurance Regulation— Other U.S. Regulation and Agency Qualification Requirements.” |
Long-Term Care Insurance segment
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | In-force rate actions. We estimate that the cumulative economic benefit of approved rate actions in our long-term care insurance multi-year in-force rate action plan since 2012 through 2024 was approximately $31.2 billion, on a net present value basis, based on our current updated assumptions regarding future premiums and benefit reductions from approved rate actions and legal settlements as described in “Results of Operations and Selected Financial and Operating Performance Measures by Segment.” This estimated cumulative economic benefit reflects meaningful progress toward reaching our latest estimate of approximately $35.8 billion for the total net present value included in our multi-year in-force rate action plan, based on our current updated assumptions. As a result, the remaining estimated amount to be achieved through future rate action approvals under our in-force rate action plan is approximately $4.6 billion. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Actual variances from expected experience. Unfavorable variances between actual and expected experience resulted in a pre-tax impact of $241 million primarily driven by lower terminations and higher claims. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Annual assumption review. As part of our annual review of cash flow assumptions in the fourth quarter of 2024, our long-term care insurance business had an unfavorable pre-tax impact of $20 million reflecting updates to better align healthy life and near-term benefit utilization assumptions with recent experience. These unfavorable impacts were largely offset by favorable assumption updates for future in-force rate action approvals based on recent experience and favorable updates to our short-term incidence assumptions for IBNR claims. See “—Critical Accounting Estimates—Liability for future policy benefits” for additional information on the impact of changes in our long-term care insurance cash flow assumptions. |
Life and Annuities segment
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Annual assumption review. As part of our annual review of cash flow assumptions in the fourth quarter of 2024, our universal life insurance products had an unfavorable pre-tax impact of $28 million reflecting updates to mortality and interest rate assumptions. See “—Critical Accounting Estimates—Policyholder account balances – additional insurance liabilities” for additional information on the impact of changes in our life insurance cash flow assumptions. Our annuity products had an unfavorable pre-tax impact of $22 million primarily from updates to our lapse assumptions. |
Capital of U.S. life insurance subsidiaries
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | As of December 31, 2024 and 2023, the consolidated RBC ratio on a company action level basis of our U.S. domiciled life insurance subsidiaries was approximately 306% and 303%, respectively. The increase was primarily attributable to statutory earnings during 2024 and an increase in the value of our |
76
Table of Contents
| Column 1 | Column 2 |
|---|---|
| limited partnership portfolio, partially offset by higher required capital as the portfolio grows. Statutory earnings reflected favorable impacts as a result of premium increases and benefit reductions from in-force rate actions and legal settlements in our long-term care insurance products and a benefit from the impact of interest rate and equity market performance in our variable annuity products. |
Capital and liquidity
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Capital returns and share repurchases. During 2024, Genworth Holdings received $289 million of capital returns from Enact Holdings, and Genworth Financial executed $186 million of share repurchases, before excise taxes and other associated costs. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Borrowings. Genworth Holdings repurchased $66 million principal amount of its debt in 2024. In June 2024, Enact Holdings redeemed all $750 million aggregate principal amount outstanding of its 6.50% senior notes due in 2025 (“2025 Notes”). Enact Holdings funded the redemption primarily through the net proceeds from the issuance of its $750 million 6.25% senior notes due in 2029 (“2029 Notes”). |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Capital contributions. We plan to invest additional capital in CareScout Services in 2025 as we continue to build out the offering. We also plan to contribute capital to our CareScout Insurance subsidiary in 2025 to meet the regulatory requirements of a new start-up insurer as we re-enter the long-term care insurance market. See “Part I—Item 1—Business—Strategic Priorities—CareScout growth initiatives.” |
Results of Operations and Selected Financial and Operating Performance Measures by Segment
Enact segment
Trends and conditions
Results of our Enact segment are affected primarily by the following factors: competitor actions; unemployment or underemployment levels; other economic and housing market trends, including interest rates, home prices, the number of first-time homebuyers, and mortgage origination volume mix and practices; the size of the overall private mortgage insurance market and the effect of regulatory actions thereon; the levels and aging of mortgage delinquencies; the effect of seasonal variations; the inventory of unsold homes; loan modification and other servicing efforts; and litigation, among other items. References to “Enact” included in “Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations—Enact segment” are, unless the context otherwise requires, to our Enact segment.
Macroeconomic environment
During 2024, the U.S. economy continued to show positive signs but faced lingering uncertainty due to inflationary pressure, the geopolitical environment and other macroeconomic concerns. Mortgage origination activity increased modestly in 2024 but remained relatively slow due to elevated mortgage rates and sustained low housing supply. Over the past few years, housing affordability has deteriorated as elevated mortgage rates and home price appreciation outpaced median family income, according to the National Association of Realtors Housing Affordability Index. National home prices continued to rise in 2024, according to the FHFA Monthly Purchase-Only House Price Index.
The unemployment rate increased to 4.1% in December 2024, compared to 3.7% in December 2023. As of December 31, 2024, the number of unemployed Americans was approximately 6.9 million, and the number of long-term unemployed over 26 weeks was approximately 1.6 million.
Forbearance and loss mitigation programs
Borrowers’ ability to utilize extended forbearance timelines permitted through the Coronavirus Aid, Relief, and Economic Security Act and the GSEs’ COVID-19 servicing-related policies ended in 2023. Borrowers that
77
Table of Contents
meet general hardship and program guidelines continue to have access to standard forbearance policies as a loss mitigation option. In addition, in March 2023, the GSEs announced new loss mitigation programs that allow six-month payment deferrals for borrowers facing financial hardship.
Although it is difficult to predict the future level of reported forbearance and how many of the loans in a forbearance plan that remain current on their monthly mortgage payment will go delinquent, servicer reported forbearances have generally declined. As of December 31, 2024, approximately 1.1% or 10,943 of Enact’s active primary policies were reported in a forbearance plan, of which approximately 34% were reported as delinquent. Approximately 9% of Enact’s primary new delinquencies in 2024 were subject to a forbearance plan compared to 13% in 2023.
Regulatory developments
Private mortgage insurance market penetration and overall market size are affected in part by actions that impact housing or housing finance policy taken by the GSEs and the U.S. government, including but not limited to, the FHA and the FHFA. In the past, these actions have included announced changes, or potential changes, to underwriting standards, including changes to the GSEs’ automated underwriting systems, FHA pricing, GSE guaranty fees, loan limits and alternative products.
On October 24, 2022, the FHFA announced its validation and approval of certain credit score models for anticipated use by the GSEs and proposed changing the required number of credit reports provided by lenders from all three nationwide consumer reporting agencies to only two. The validation of the new credit scores is currently expected to require lenders to deliver both credit scores for each loan sold to the GSEs. Implementation, which has been delayed beyond 2025, will require system and process updates.
Competitive environment
The U.S. private mortgage insurance industry is highly competitive. Enact Holdings’ market share is influenced by the execution of its go to market strategy, including but not limited to, pricing competitiveness relative to its peers and its selective participation in forward commitment transactions. Enact continues to manage the quality of new business through pricing and its underwriting guidelines, which are modified from time to time when circumstances warrant. The market and underwriting conditions, including the mortgage insurance pricing environment, are within Enact’s risk adjusted return appetite, enabling it to write new business at returns it views as attractive.
Mortgage insurance portfolio
New insurance written of $51.0 billion in 2024 decreased 4% compared to 2023. Changes in new insurance written are primarily impacted by the size of the mortgage insurance market and Enact’s market share. Enact’s primary persistency rate was 83% for the year ended December 31, 2024 compared to 85% for the year ended December 31, 2023. Persistency remained elevated in 2024 but decreased compared to 2023 due to rate volatility. Elevated persistency continued to offset lower new insurance written, contributing to an increase in primary insurance in-force of $5.9 billion during 2024.
Net earned premiums increased in 2024 compared to 2023 primarily driven by insurance in-force growth and higher assumed premiums, mostly consisting of Enact Re’s GSE credit risk transfer participation and multifamily reinsurance, partially offset by higher ceded premiums.
Loss experience
Enact’s loss ratio was 4% for the year ended December 31, 2024, compared to 3% for the year ended December 31, 2023. Enact released reserves of $252 million during 2024 primarily driven by favorable cure
78
Table of Contents
performance on delinquencies from prior years and loss mitigation activities. As part of the reserve adjustments in 2024, Enact decreased its claim rate assumptions largely as a result of sustained favorable cure performance and lessening uncertainty in the economic environment, impacting both current and prior year delinquencies. Enact released reserves of $241 million in 2023 primarily related to favorable cure performance on delinquencies from 2022 and earlier, including those related to COVID-19.
The severity of loss on loans that go to claim may be negatively impacted by extended forbearance and foreclosure timelines, the associated elevated expenses and the higher loan amount of recent new delinquencies. These negative influences on loss severity could be mitigated in part by embedded home price appreciation. For loans insured on or after October 1, 2014, Enact’s mortgage insurance policies limit the number of months of unpaid interest and associated expenses that are included in the mortgage insurance claim amount to a maximum of 36 months.
New primary delinquencies for the year ended December 31, 2024 increased compared to the year ended December 31, 2023, primarily due to the aging of large, newer books of business. New primary delinquencies of 48,537 contributed $287 million of loss expense in 2024, while Enact incurred $265 million of losses from 41,617 new primary delinquencies in 2023. In determining the loss expense estimate, considerations were given to recent cure and claim experience and the prevailing and prospective economic conditions.
Capital requirements
As of December 31, 2024, EMICO’s risk-to-capital ratio under North Carolina law and enforced by the NCDOI, EMICO’s domestic insurance regulator, was approximately 10.5:1, compared with a risk-to-capital ratio of 11.6:1 as of December 31, 2023. EMICO’s risk-to-capital ratio remains below the NCDOI’s maximum risk-to-capital ratio of 25:1. North Carolina’s calculation of risk-to-capital excludes the risk in-force for delinquent loans given the established loss reserves against all delinquencies. EMICO’s ongoing risk-to-capital ratio will depend principally on the magnitude of future losses incurred by EMICO, the effectiveness of ongoing loss mitigation activities, new business volume and profitability, the impact of quota share reinsurance, the amount of policy lapses and the amount of additional capital that is generated or distributed by the business.
Under PMIERs, Enact is subject to operational and financial requirements that private mortgage insurers must meet in order to remain eligible to insure loans that are purchased by the GSEs. As of December 31, 2024, Enact had estimated available assets of $5,095 million against $3,043 million net required assets under PMIERs compared to available assets of $5,006 million against $3,119 million net required assets as of December 31, 2023. The sufficiency ratio as of December 31, 2024 was 167% or $2,052 million above the PMIERs requirements, compared to 161% or $1,887 million above the PMIERs requirements as of December 31, 2023.
Enact’s PMIERs required assets as of December 31, 2024 and 2023 benefited from the application of a 0.30 multiplier applied to the risk based required asset amount factor for certain non-performing loans as defined under PMIERs. The application of the 0.30 multiplier to all eligible delinquencies provided $28 million and $73 million, respectively, of benefit to Enact’s December 31, 2024 and 2023 PMIERs required assets. Enact’s third-party reinsurance transactions provided an aggregate of approximately $1,885 million and $1,714 million of PMIERs capital credit as of December 31, 2024 and 2023, respectively. These amounts are gross of any incremental reinsurance benefit from the elimination of the 0.30 multiplier. Per guidance released by the GSEs in the third quarter of 2024, use of the multiplier will be discontinued effective March 31, 2025.
On August 21, 2024, the GSEs and the FHFA released updated PMIERs requirements phasing in a revision to the available assets standards between March 31, 2025 and September 30, 2026. Enact expects to hold capital sufficiency well in excess of these requirements and does not expect the impact of these updates to be material to its sufficiency. For additional details, see “Item 1—Regulation—Enact—Mortgage Insurance Regulation—Other U.S. Regulation and Agency Qualification Requirements.”
79
Table of Contents
Recent transactions
During 2024, Enact executed excess of loss reinsurance transactions that provide up to $270 million of reinsurance coverage on a portion of its new insurance written in 2024 and $90 million of reinsurance coverage on a portion of its existing new insurance written between July 2023 and December 2023. Enact also executed quota share reinsurance agreements under which it ceded approximately 21% of a portion of new insurance written for its 2024 book year and will cede, subject to certain conditions, approximately 27% of a portion of expected new insurance written for each of its 2025 and 2026 book years.
On January 27, 2025, Enact executed two excess of loss reinsurance transactions that provide approximately $225 million and $260 million, respectively, of reinsurance coverage on a portion of expected new insurance written for the 2025 and 2026 book years. See note 7 in our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for additional details on Enact’s reinsurance transactions. Enact may execute future credit risk transfer transactions to maintain a prudent level of financial flexibility in excess of the PMIERs capital requirements in response to potential changes in performance and PMIERs requirements over time.
Capital returns
In November 2024, EMICO completed a distribution to Enact Holdings that supports its ability to pay a quarterly dividend. Future dividend payments are subject to quarterly review and approval by Enact Holdings’ board of directors and Genworth Financial. In addition to Enact’s quarterly dividend program, Enact Holdings announced approval by its board of directors on May 1, 2024 of a share repurchase program which allows for the repurchase of up to $250 million of its common stock. Genworth Holdings has agreed to participate in share repurchases in order to maintain its overall ownership at approximately its current level. As the majority shareholder, Genworth Holdings received $289 million of capital returns from Enact Holdings during 2024, comprised of $91 million of quarterly dividends and $198 million of share repurchases.
Returning capital to shareholders, balanced with growth and risk management priorities, remains a priority for Enact Holdings as it looks to enhance shareholder value through time. Future return of capital will be shaped by Enact Holdings’ capital prioritization framework, which sets the following priorities: supporting its existing policyholders, growing its mortgage insurance business, funding attractive new business opportunities and returning capital to shareholders. Enact Holdings’ total return of capital will also be based on its view of the prevailing and prospective macroeconomic conditions, regulatory landscape and business performance.
80
Table of Contents
Segment results of operations
The following table sets forth the results of operations relating to our Enact segment for the periods indicated:
| Years ended December 31, | Increase (decrease) and percentage change | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (Amounts in millions) | 2024 | 2023 | 2022 | 2024 vs. 2023 | ||||||||||||||||
| Revenues: | ||||||||||||||||||||
| Premiums | $ | 980 | $ | 957 | $ | 940 | $ | 23 | 2 | % | ||||||||||
| Net investment income | 240 | 208 | 155 | 32 | 15 | % | ||||||||||||||
| Net investment gains (losses) | (22 | ) | (14 | ) | (2 | ) | (8 | ) | (57 | )% | ||||||||||
| Policy fees and other income | 4 | 2 | 2 | 2 | 100 | % | ||||||||||||||
| Total revenues | 1,202 | 1,153 | 1,095 | 49 | 4 | % | ||||||||||||||
| Benefits and expenses: | ||||||||||||||||||||
| Benefits and other changes in policy reserves | 39 | 27 | (94 | ) | 12 | 44 | % | |||||||||||||
| Acquisition and operating expenses, net of deferrals | 224 | 212 | 227 | 12 | 6 | % | ||||||||||||||
| Amortization of deferred acquisition costs and intangibles | 10 | 11 | 12 | (1 | ) | (9 | )% | |||||||||||||
| Interest expense | 51 | 52 | 52 | (1 | ) | (2 | )% | |||||||||||||
| Total benefits and expenses | 324 | 302 | 197 | 22 | 7 | % | ||||||||||||||
| Income from continuing operations before income taxes | 878 | 851 | 898 | 27 | 3 | % | ||||||||||||||
| Provision for income taxes | 190 | 186 | 194 | 4 | 2 | % | ||||||||||||||
| Income from continuing operations | 688 | 665 | 704 | 23 | 3 | % | ||||||||||||||
| Less: net income attributable to noncontrolling interests | 128 | 123 | 130 | 5 | 4 | % | ||||||||||||||
| Income from continuing operations available to Genworth Financial, Inc.’s common stockholders | 560 | 542 | 574 | 18 | 3 | % | ||||||||||||||
| Adjustments to income from continuing operations available to Genworth Financial, Inc.’s common stockholders: | ||||||||||||||||||||
| Net investment (gains) losses, net (1) | 18 | 12 | 2 | 6 | 50 | % | ||||||||||||||
| (Gains) losses on early extinguishment of debt, net (2) | 9 | — | — | 9 | NM | (3) | ||||||||||||||
| Expenses related to restructuring | 4 | — | 3 | 4 | NM | (3) | ||||||||||||||
| Taxes on adjustments | (6 | ) | (2 | ) | (1 | ) | (4 | ) | (200 | )% | ||||||||||
| Adjusted operating income available to Genworth Financial, Inc.’s common stockholders | $ | 585 | $ | 552 | $ | 578 | $ | 33 | 6 | % |
| Column 1 | Column 2 |
|---|---|
| (1) | For the years ended December 31, 2024 and 2023, net investment (gains) losses were adjusted for the portion attributable to noncontrolling interests of $4 million and $2 million, respectively. |
| Column 1 | Column 2 |
|---|---|
| (2) | For the year ended December 31, 2024, (gains) losses on the early extinguishment of debt were net of the portion attributable to noncontrolling interests of $2 million. |
| Column 1 | Column 2 |
|---|---|
| (3) | We define “NM” as not meaningful for increases or decreases greater than 200%. |
2024 compared to 2023
Adjusted operating income available to Genworth Financial, Inc.’s common stockholders
Adjusted operating income increased primarily attributable to higher net investment income and premiums, partially offset by higher new delinquencies in 2024.
81
Table of Contents
Revenues
Premiums increased mainly driven by insurance in-force growth and higher assumed premiums, mostly consisting of Enact Re’s GSE credit risk transfer participation and multifamily reinsurance, partially offset by higher ceded premiums in 2024.
Net investment income increased primarily from higher investment yields and higher average invested assets in 2024.
For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”
Benefits and expenses
Benefits and other changes in policy reserves increased primarily driven by higher new delinquencies, partially offset by higher favorable reserve adjustments in 2024. Enact released reserves of $252 million in 2024 primarily related to favorable cure performance on delinquencies from prior years and loss mitigation activities. During 2023, Enact released $241 million of reserves primarily related to favorable cure performance on prior year delinquencies, including those related to COVID-19.
Acquisition and operating expenses, net of deferrals, increased primarily due to an $11 million loss on the early redemption of Enact Holdings’ 2025 Notes in 2024.
Provision for income taxes. The effective tax rate was 21.6% and 21.8% for the years ended December 31, 2024 and 2023, respectively, consistent with the U.S. corporate federal income tax rate.
Enact selected operating performance measures
Management’s discussion and analysis of our Enact segment contains selected operating performance measures including “new insurance written,” “insurance in-force” and “risk in-force,” which are commonly used in the insurance industry as measures of operating performance.
Management regularly monitors and reports new insurance written for our Enact segment as a measure of volume of new business generated in a period. We consider new insurance written to be a measure of our Enact segment’s operating performance because it represents a measure of new sales of mortgage insurance policies during a specified period, rather than a measure of revenues or profitability during that period.
Management also regularly monitors and reports insurance in-force and risk in-force for our Enact segment. Insurance in-force is a measure of the aggregate unpaid principal balance as of the respective reporting date for loans insured by our U.S. mortgage insurance subsidiaries. Risk in-force is based on the coverage percentage applied to the estimated current outstanding loan balance. These metrics are presented on a direct basis and exclude reinsurance. We consider insurance in-force and risk in-force to be measures of our Enact segment’s operating performance because they represent measures of the size of its business at a specific date which will generate revenues and profits in a future period, rather than measures of its revenues or profitability during that period.
Management also regularly monitors and reports a loss ratio and an expense ratio for our Enact segment. We consider the loss ratio, which is the ratio of benefits and other changes in policy reserves to net earned premiums, to be a measure of underwriting performance. The expense ratio is the ratio of general expenses to net earned premiums. Enact’s general expenses consist of acquisition and operating expenses, net of deferrals, and amortization of DAC and intangibles. We believe these ratios help to enhance the understanding of the operating performance of our Enact segment.
82
Table of Contents
The following table sets forth selected operating performance measures regarding Enact as of and for the dates indicated:
| Years ended December 31, | Increase (decrease) and percentage change | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (Amounts in millions) | 2024 | 2023 | 2022 | 2024 vs. 2023 | ||||||||||||||||
| Primary insurance in-force | $ | 268,825 | $ | 262,937 | $ | 248,262 | $ | 5,888 | 2 | % | ||||||||||
| Risk in-force: | ||||||||||||||||||||
| Primary | $ | 69,985 | $ | 67,529 | $ | 62,791 | $ | 2,456 | 4 | % | ||||||||||
| Pool | 57 | 69 | 79 | (12 | ) | (17 | )% | |||||||||||||
| Total risk in-force | $ | 70,042 | $ | 67,598 | $ | 62,870 | $ | 2,444 | 4 | % | ||||||||||
| New insurance written | $ | 51,002 | $ | 53,081 | $ | 66,485 | $ | (2,079 | ) | (4 | )% |
2024 compared to 2023
Primary insurance in-force and risk in-force
Primary insurance in-force increased mainly from new insurance written and elevated persistency, partially offset by lapses and cancellations. The primary persistency rate was 83% and 85% for the years ended December 31, 2024 and 2023, respectively. Total risk in-force increased primarily as a result of higher primary insurance in-force.
New insurance written
Changes in new insurance written are primarily impacted by the size of the mortgage insurance market and Enact’s market share.
Loss and expense ratios
The following table sets forth the loss and expense ratios for Enact for the dates indicated:
| Years ended December 31, | Increase (decrease) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | 2022 | 2024 vs. 2023 | |||||||||||||
| Loss ratio | 4 | % | 3 | % | (10 | )% | 1 | % | ||||||||
| Expense ratio | 24 | % | 23 | % | 25 | % | 1 | % |
The loss ratio increased largely from higher new delinquencies, partially offset by higher favorable reserve adjustments in 2024, as discussed above.
The expense ratio increased primarily due to an $11 million loss on the early redemption of Enact Holdings’ 2025 Notes, which increased the expense ratio by one percentage point in 2024.
83
Table of Contents
Mortgage insurance loan portfolio
The following table sets forth selected financial information regarding Enact’s loan portfolio as of December 31:
| (Amounts in millions) | 2024 | 2023 | 2022 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary insurance in-force by loan-to-value ratio at origination: | |||||||||||
| 95.01% and above | $ | 50,318 | $ | 44,955 | $ | 39,509 | |||||
| 90.01% to 95.00% | 112,362 | 109,227 | 103,618 | ||||||||
| 85.01% to 90.00% | 79,932 | 77,887 | 72,132 | ||||||||
| 85.00% and below | 26,213 | 30,868 | 33,003 | ||||||||
| Total | $ | 268,825 | $ | 262,937 | $ | 248,262 | |||||
| Primary risk in-force by loan-to-value ratio at origination: | |||||||||||
| 95.01% and above | $ | 14,428 | $ | 12,878 | $ | 11,136 | |||||
| 90.01% to 95.00% | 32,686 | 31,781 | 30,079 | ||||||||
| 85.01% to 90.00% | 19,729 | 19,163 | 17,621 | ||||||||
| 85.00% and below | 3,142 | 3,707 | 3,955 | ||||||||
| Total | $ | 69,985 | $ | 67,529 | $ | 62,791 | |||||
| Primary insurance in-force by credit quality at origination: | |||||||||||
| Over 760 | $ | 115,554 | $ | 110,635 | $ | 102,467 | |||||
| 740—759 | 43,955 | 43,053 | 40,097 | ||||||||
| 720—739 | 37,717 | 37,020 | 34,916 | ||||||||
| 700—719 | 29,819 | 29,766 | 28,867 | ||||||||
| 680—699 | 21,355 | 21,835 | 21,554 | ||||||||
| 660—679(1) | 11,245 | 11,357 | 10,926 | ||||||||
| 640—659 | 6,147 | 6,137 | 6,095 | ||||||||
| 620—639 | 2,461 | 2,504 | 2,630 | ||||||||
| 620 | 572 | 630 | 710 | ||||||||
| Total | $ | 268,825 | $ | 262,937 | $ | 248,262 | |||||
| Primary risk in-force by credit quality at origination: | |||||||||||
| Over 760 | $ | 29,985 | $ | 28,363 | $ | 25,807 | |||||
| 740—759 | 11,494 | 11,096 | 10,154 | ||||||||
| 720—739 | 9,949 | 9,621 | 8,931 | ||||||||
| 700—719 | 7,746 | 7,623 | 7,317 | ||||||||
| 680—699 | 5,523 | 5,557 | 5,428 | ||||||||
| 660—679(1) | 2,924 | 2,908 | 2,767 | ||||||||
| 640—659 | 1,589 | 1,565 | 1,540 | ||||||||
| 620—639 | 629 | 635 | 665 | ||||||||
| 620 | 146 | 161 | 182 | ||||||||
| Total | $ | 69,985 | $ | 67,529 | $ | 62,791 |
| Column 1 | Column 2 |
|---|---|
| (1) | Loans with unknown FICO scores are included in the 660-679 category. |
The FICO credit score is one indicator of a borrower’s credit quality. Enact continues to underwrite predominantly prime loan new business. Based upon FICO at loan closing, the weighted average FICO score of Enact’s primary insurance in-force was 745 as of December 31, 2024.
84
Table of Contents
Delinquent loans and claims
Enact’s delinquency management process begins with notification by the loan servicer of a delinquency on an insured loan. “Delinquency” is defined in Enact’s master policies as the borrower’s failure to pay when due an amount equal to the scheduled monthly mortgage payment under the terms of the mortgage. Generally, the master policies require an insured to notify Enact of a delinquency if the borrower fails to make two consecutive monthly mortgage payments prior to the due date of the next mortgage payment. Enact generally considers a loan to be delinquent and establishes required reserves after the insured gives notification that the borrower has failed to make two scheduled mortgage payments. Borrowers default for a variety of reasons, including a reduction of income, unemployment, divorce, illness/death, inability to manage credit, falling home prices and interest rate levels. Borrowers may cure delinquencies by making all of the delinquent loan payments, agreeing to a loan modification or by selling the property in full satisfaction of all amounts due under the mortgage. In most cases, delinquencies that are not cured result in a claim under Enact’s policy. The following table sets forth the number of loans insured, the number of delinquent loans and the delinquency rate for Enact’s loan portfolio as of December 31:
| 2024 | 2023 | 2022 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary insurance: | ||||||||||||
| Insured loans in-force | 962,849 | 974,516 | 960,306 | |||||||||
| Delinquent loans | 23,566 | 20,432 | 19,943 | |||||||||
| Percentage of delinquent loans (delinquency rate) | 2.45 | % | 2.10 | % | 2.08 | % |
The delinquency rate as of December 31, 2024 increased compared to December 31, 2023 primarily from an increase in total delinquencies mostly driven by new delinquencies outpacing cures and paid claims.
The following tables set forth primary delinquencies, direct primary case reserves and risk in-force by aged missed payment status in Enact’s loan portfolio as of December 31:
| 2024 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (Dollar amounts in millions) | Delinquencies | Direct primary case reserves(1) | Risk in-force | Reserves as % of risk in-force | ||||||||||||
| Payments in default: | ||||||||||||||||
| 3 payments or less | 12,712 | $ | 108 | $ | 849 | 13 | % | |||||||||
| 4 - 11 payments | 7,701 | 191 | 545 | 35 | % | |||||||||||
| 12 payments or more | 3,153 | 173 | 213 | 81 | % | |||||||||||
| Total | 23,566 | $ | 472 | $ | 1,607 | 29 | % |
| Column 1 | Column 2 |
|---|---|
| (1) | Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves. |
| 2023 | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (Dollar amounts in millions) | Delinquencies | Direct primary case reserves(1) | Risk in-force | Reserves as % of risk in-force | ||||||||||||
| Payments in default: | ||||||||||||||||
| 3 payments or less | 10,166 | $ | 88 | $ | 629 | 14 | % | |||||||||
| 4 - 11 payments | 6,934 | 205 | 469 | 44 | % | |||||||||||
| 12 payments or more | 3,332 | 184 | 200 | 92 | % | |||||||||||
| Total | 20,432 | $ | 477 | $ | 1,298 | 37 | % |
| Column 1 | Column 2 |
|---|---|
| (1) | Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves. |
Reserves as a percentage of risk in-force as of December 31, 2024 decreased compared to December 31, 2023 as Enact has experienced cures among long-term delinquencies with higher reserves and has reduced the expected claim rate on new delinquencies.
85
Table of Contents
Primary insurance delinquency rates differ from region to region in the United States at any one time depending upon economic conditions and cyclical growth patterns. The tables below set forth the dispersion of direct primary case reserves and primary delinquency rates for the 10 largest states and the 10 largest Metropolitan Statistical Areas (“MSA”) or Metro Divisions (“MD”) by Enact’s primary risk in-force as of the dates indicated. Delinquency rates are shown by region based upon the location of the underlying property, rather than the location of the lender.
| % of primary risk in-force as of December 31, 2024 | % of direct primary case reserves as of December 31, 2024(1) | Delinquency rate as of December 31, | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | 2022 | ||||||||||||||||||
| By State: | ||||||||||||||||||||
| California | 12 | % | 12 | % | 2.53 | % | 2.22 | % | 2.09 | % | ||||||||||
| Texas | 9 | % | 9 | % | 2.64 | % | 2.22 | % | 2.12 | % | ||||||||||
| Florida(2) | 8 | % | 12 | % | 3.67 | % | 2.39 | % | 2.54 | % | ||||||||||
| New York(2) | 5 | % | 10 | % | 3.30 | % | 3.05 | % | 2.95 | % | ||||||||||
| Illinois(2) | 4 | % | 6 | % | 2.96 | % | 2.61 | % | 2.54 | % | ||||||||||
| Arizona | 4 | % | 3 | % | 2.35 | % | 1.93 | % | 1.78 | % | ||||||||||
| Michigan | 4 | % | 3 | % | 2.14 | % | 1.94 | % | 1.79 | % | ||||||||||
| Georgia | 3 | % | 4 | % | 3.02 | % | 2.23 | % | 2.23 | % | ||||||||||
| North Carolina | 3 | % | 2 | % | 2.14 | % | 1.56 | % | 1.59 | % | ||||||||||
| Pennsylvania | 3 | % | 3 | % | 2.17 | % | 2.19 | % | 2.17 | % |
| Column 1 | Column 2 |
|---|---|
| (1) | Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves. |
| Column 1 | Column 2 |
|---|---|
| (2) | Jurisdiction predominantly uses a judicial foreclosure process, which generally increases the amount of time it takes for a foreclosure to be completed. |
| % of primary risk in-force as of December 31, 2024 | % of direct primary case reserves as of December 31, 2024(1) | Delinquency rate as of December 31, | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | 2022 | ||||||||||||||||||
| By MSA or MD: | ||||||||||||||||||||
| Phoenix, AZ MSA | 3 | % | 3 | % | 2.41 | % | 2.01 | % | 1.83 | % | ||||||||||
| Chicago-Naperville, IL MD | 3 | % | 4 | % | 3.29 | % | 2.88 | % | 2.84 | % | ||||||||||
| Atlanta, GA MSA | 3 | % | 3 | % | 3.02 | % | 2.40 | % | 2.42 | % | ||||||||||
| New York, NY MD | 2 | % | 6 | % | 3.53 | % | 3.60 | % | 3.75 | % | ||||||||||
| Houston, TX MSA | 2 | % | 3 | % | 3.58 | % | 2.67 | % | 2.60 | % | ||||||||||
| Dallas, TX MD | 2 | % | 2 | % | 2.38 | % | 1.92 | % | 1.86 | % | ||||||||||
| Washington-Arlington, DC MD | 2 | % | 2 | % | 2.03 | % | 2.01 | % | 1.85 | % | ||||||||||
| Riverside-San Bernardino, CA MSA | 2 | % | 3 | % | 3.25 | % | 2.83 | % | 2.89 | % | ||||||||||
| Los Angeles-Long Beach, CA MD | 2 | % | 2 | % | 2.65 | % | 2.39 | % | 2.18 | % | ||||||||||
| Denver-Aurora-Lakewood, CO MSA | 2 | % | 1 | % | 1.38 | % | 1.12 | % | 1.12 | % |
| Column 1 | Column 2 |
|---|---|
| (1) | Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves. |
The number of delinquencies may not correlate directly with the number of claims received because delinquencies may cure. The rate at which delinquencies cure is influenced by borrowers’ financial resources and circumstances and regional economic differences. Whether a delinquency leads to a claim correlates highly with the borrower’s equity at the time of delinquency, as it influences the borrower’s willingness to continue to make payments, and the borrower’s or the insured’s ability to sell the home for an amount sufficient to satisfy all amounts due under the mortgage loan, as well as the borrower’s financial ability to continue making payments. When Enact receives notice of a delinquency, it uses its proprietary model to determine whether a delinquent loan is a candidate for a modification. When the model identifies such a candidate, Enact’s loan workout specialists prioritize cases for loss mitigation based upon the likelihood that the loan will result in a claim. Loss mitigation actions include loan modification, extension of credit to bring a loan current, foreclosure forbearance, pre-foreclosure sale and deed-in-lieu. These loss mitigation efforts often are an effective way to reduce Enact’s claim exposure and ultimate payouts.
86
Table of Contents
The following table sets forth the dispersion of Enact’s direct primary case reserves, primary insurance in-force and risk in-force by year of policy origination, as well as weighted average mortgage interest rate and delinquency rate as of December 31, 2024:
| (Amounts in millions) | Weighted average rate (1) | % of direct primary case reserves(2) | Primary insurance in-force | % of total | Primary risk in-force | % of total | Delinquency rate | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Policy Year 2008 and prior | 5.33 | % | 10 | % | $ | 4,860 | 2 | % | $ | 1,256 | 2 | % | 8.17 | % | ||||||||||||||
| 2009 to 2016 | 4.00 | % | 6 | 5,138 | 2 | 1,332 | 2 | 4.75 | % | |||||||||||||||||||
| 2017 | 4.32 | % | 4 | 3,907 | 1 | 1,036 | 1 | 4.37 | % | |||||||||||||||||||
| 2018 | 4.83 | % | 5 | 4,790 | 2 | 1,233 | 2 | 4.66 | % | |||||||||||||||||||
| 2019 | 4.23 | % | 8 | 11,415 | 4 | 2,984 | 4 | 3.31 | % | |||||||||||||||||||
| 2020 | 3.26 | % | 14 | 34,940 | 13 | 9,553 | 14 | 2.14 | % | |||||||||||||||||||
| 2021 | 3.11 | % | 21 | 57,266 | 21 | 15,043 | 21 | 2.25 | % | |||||||||||||||||||
| 2022 | 4.88 | % | 20 | 53,063 | 20 | 13,476 | 19 | 2.50 | % | |||||||||||||||||||
| 2023 | 6.62 | % | 10 | 45,208 | 17 | 11,719 | 17 | 1.83 | % | |||||||||||||||||||
| 2024 | 6.70 | % | 2 | 48,238 | 18 | 12,353 | 18 | 0.49 | % | |||||||||||||||||||
| Total portfolio | 4.88 | % | 100 | % | $ | 268,825 | 100 | % | $ | 69,985 | 100 | % | 2.45 | % |
| Column 1 | Column 2 |
|---|---|
| (1) | Average annual mortgage interest rate weighted by insurance in-force. |
| Column 1 | Column 2 |
|---|---|
| (2) | Direct primary case reserves exclude loss adjustment expenses, pool, IBNR and reinsurance reserves. |
Loss reserves in policy years 2008 and prior are outsized compared to their representation of risk in-force. The size of these policy years at origination combined with the significant decline in home prices led to significant losses in policy years prior to 2009. Although uncertainty remains with respect to the ultimate losses Enact will experience on these policy years, they have become a smaller percentage of its total mortgage insurance portfolio. The concentration of loss reserves has shifted to newer book years in line with changes in risk in-force. As of December 31, 2024, Enact’s 2017 and newer policy years represented approximately 96% of its primary risk in-force and 84% of its total direct primary case reserves.
The ratio of the claim paid to the current risk in-force for a loan is referred to as “claim severity.” The current risk in-force is equal to the unpaid principal amount multiplied by the coverage percentage. The main determinants of claim severity are the age of the mortgage loan, the value of the underlying property, accrued interest on the loan, expenses advanced by the insured and foreclosure expenses. These amounts depend partly upon the time required to complete foreclosure, which varies depending upon state laws. Pre-foreclosure sales, acquisitions and other early workout and claim administration actions help to reduce overall claim severity. Enact’s average primary mortgage insurance claim severity was 99%, 97% and 94% for the years ended December 31, 2024, 2023 and 2022, respectively, and was impacted by low claim volumes and lifetime home price appreciation. The average claim severities do not include the effects of agreements on non-performing loans.
Long-Term Care Insurance segment
Trends and conditions
The results of our long-term care insurance business depend upon how our actual experience compares with our valuation assumptions, including but not limited to in-force rate actions, morbidity, mortality and persistency. Estimates for in-force rate actions reflect certain simplifying assumptions that may vary materially from actual results, including but not limited to consistent policyholder behavior over time in addition to a uniform rate of coinsurance and premium taxes. Actual policyholder behavior may differ significantly from these assumptions. Results of our long-term care insurance business are also influenced by our ability to improve investment yields and manage expenses and reinsurance, among other factors. Changes in laws or government programs, including long-term care insurance rate action legislation, regulation and/or practices, also impact our long-term care insurance business either positively or negatively.
87
Table of Contents
Because these factors are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments as our actual claims experience will emerge over many years, or decades. For example, average claim reserves for new claims have trended higher over time as the mix of claims continues to evolve, with an increasing number of policies with higher daily benefit amounts and higher inflation factors going on claim. Although new claim counts on certain of our oldest long-term care insurance blocks of business have reached their peak claim years and will decrease as the blocks run off, we expect overall claims costs to continue to increase as the approximately 609,000 insured individuals in our two largest blocks, Choice I and Choice II, with average attained ages of 77 and 74, respectively, reach their peak claim years, which are over age 85.
Additionally, we have observed an increase in the cost of care in our long-term care insurance business, due in part to elevated inflation. Increases in cost of care have resulted in higher claim payments, which could have a material adverse impact on our liquidity, results of operations and financial condition if the increases persist. We will continue to monitor our experience and make changes to our assumptions and methodologies, as appropriate, for our long-term care insurance products. Even small changes in assumptions or small deviations of actual experience from assumptions could have, and in the past have had, material impacts on our reserve levels, results of operations and financial condition.
The impacts of assumption updates and actual variances from expected experience will continue to drive volatility in our long-term care insurance results, particularly for our unprofitable capped cohorts. Our profitable uncapped cohorts have to date had a more modest earnings impact related to assumption updates and actual variances from expected experience, as a portion of the impact is reflected in current period results with the remaining majority of the impact recognized over the life of the cohort. However, as we move further from the January 2021 transition date of the accounting guidance for long-duration insurance contracts adopted on January 1, 2023, we may see increased volatility from the uncapped cohorts, with more of the impact related to assumption updates and actual variances from expected experience recognized immediately in net income. It is important to note that quarterly variations resulting from assumption updates and actual variances from expected experience are typically expected to be relatively small compared to the overall size of our liability for future policy benefits of $43.0 billion, at the locked-in discount rate, for our long-term care insurance business as of December 31, 2024.
For a discussion of potential impacts of assumption updates and actual variances from expected experience on our results of operations, see “Item 1A—Risk Factors—We may be required to increase our reserves as a result of deviations from our estimates and actuarial assumptions or other reasons, which could have a material adverse effect on our business, results of operations and financial condition.”
The financial condition of our long-term care insurance business is also impacted by interest rates. We remeasure our liability for future policy benefits and the related reinsurance recoverables at the single-A bond rate each quarter. As a result, our reported insurance liabilities are sensitive to movements in interest rates, which will likely result in continued volatility to our reserve balances and equity. For a discussion of the potential impacts and risks associated with changes in interest rates, see “Item 1A—Risk Factors—Interest rates and changes in rates could materially adversely affect our business and profitability.”
Fourth quarter assumption review
In the fourth quarter of 2024, our long-term care insurance products had an unfavorable pre-tax impact of $20 million from cash flow assumption updates primarily related to updates to our healthy life and near-term benefit utilization assumptions to better align with recent experience, including cost of care inflation. Although we did not make significant changes to our multi-year in-force rate action plan, these unfavorable impacts were partially offset by favorable assumption updates for future in-force rate action approvals given our current plans for rate increase filings and our recent experience regarding approvals and regulatory support. The unfavorable
88
Table of Contents
impacts were also partially offset by favorable updates to our short-term incidence assumptions for IBNR claims, reducing sufficiency held through a period of heightened uncertainty around incidence during and immediately following COVID-19. While our 2024 assumption review considered trends during the pandemic years, our updates to long-term assumptions generally exclude or adjust experience data after 2019, as we do not have sufficient information around the long-term effects of COVID-19.
Under statutory cash flow testing, changes impacting active life reserves are included in our margin review and only impact statutory income if the margin falls below zero. However, changes to our claim reserve assumptions are immediately reflected in statutory income. We completed statutory cash flow testing for our life insurance subsidiaries in the fourth quarter of 2024 and concluded that the margin in GLIC was positive and within the $0.5 billion to $1.0 billion range. However, GLICNY had a negative margin and recorded additional statutory reserves of $79 million in 2024.
In-force rate actions and legal settlements
Given the ongoing challenges in our long-term care insurance business, we continue to pursue initiatives to improve the risk and profitability profile of our business, including premium rate increases and associated benefit reductions on our in-force policies. Executing on our multi-year long-term care insurance in-force rate action plan with premium rate increases and associated benefit reductions on our legacy long-term care insurance policies is critical to the business. For an update on in-force rate actions, refer to the selected operating performance measures below.
In addition, we have reached three legal settlements regarding alleged disclosure deficiencies in premium increases for long-term care insurance policies. These legal settlements cover approximately 70% of our long-term care insurance block and have had the effect of accelerating benefit reductions. We began implementing the third and final legal settlement during the second quarter of 2023, and its implementation was materially completed in the fourth quarter of 2024. These legal settlements resulted in an overall net favorable economic impact to our long-term care insurance business as they reduced tail risk on these long-duration liabilities.
While we expect renewal premiums to decline over time as the block runs off, benefit reductions elected by policyholders in connection with our in-force rate actions and legal settlements have accelerated that decline. However, we expect this decline to be partially offset by future approved rate actions.
89
Table of Contents
Segment results of operations
The following table sets forth the results of operations relating to our Long-Term Care Insurance segment for the periods indicated:
| Years ended December 31, | Increase (decrease) and percentage change | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (Amounts in millions) | 2024 | 2023 | 2022 | 2024 vs. 2023 | ||||||||||||||||
| Revenues: | ||||||||||||||||||||
| Premiums | $ | 2,310 | $ | 2,463 | $ | 2,500 | $ | (153 | ) | (6 | )% | |||||||||
| Net investment income | 1,940 | 1,914 | 1,900 | 26 | 1 | % | ||||||||||||||
| Net investment gains (losses) | 66 | 114 | 19 | (48 | ) | (42 | )% | |||||||||||||
| Total revenues | 4,316 | 4,491 | 4,419 | (175 | ) | (4 | )% | |||||||||||||
| Benefits and expenses: | ||||||||||||||||||||
| Benefits and other changes in policy reserves | 3,774 | 3,802 | 3,788 | (28 | ) | (1 | )% | |||||||||||||
| Liability remeasurement (gains) losses | 172 | 321 | (317 | ) | (149 | ) | (46 | )% | ||||||||||||
| Acquisition and operating expenses, net of deferrals | 423 | 452 | 413 | (29 | ) | (6 | )% | |||||||||||||
| Amortization of deferred acquisition costs and intangibles | 69 | 71 | 74 | (2 | ) | (3 | )% | |||||||||||||
| Total benefits and expenses | 4,438 | 4,646 | 3,958 | (208 | ) | (4 | )% | |||||||||||||
| Income (loss) from continuing operations before income taxes | (122 | ) | (155 | ) | 461 | 33 | 21 | % | ||||||||||||
| Provision (benefit) for income taxes | 3 | (3 | ) | 125 | 6 | 200 | % | |||||||||||||
| Income (loss) from continuing operations | (125 | ) | (152 | ) | 336 | 27 | 18 | % | ||||||||||||
| Adjustments to income (loss) from continuing operations: | ||||||||||||||||||||
| Net investment (gains) losses | (66 | ) | (114 | ) | (19 | ) | 48 | 42 | % | |||||||||||
| Expenses related to restructuring | 1 | — | (1 | ) | 1 | NM | (1) | |||||||||||||
| Taxes on adjustments | 14 | 24 | 4 | (10 | ) | (42 | )% | |||||||||||||
| Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders | $ | (176 | ) | $ | (242 | ) | $ | 320 | $ | 66 | 27 | % |
| Column 1 | Column 2 |
|---|---|
| (1) | We define “NM” as not meaningful for increases or decreases greater than 200%. |
2024 compared to 2023
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders
The adjusted operating loss decreased primarily driven by lower liability remeasurement losses, net insurance recoveries and higher income from limited partnerships, partially offset by lower renewal premiums in 2024.
Revenues
Premiums decreased primarily driven by lower renewal premiums from benefit reduction elections made by policyholders in connection with our in-force rate actions and legal settlements and from policy terminations in 2024. The decrease was partially offset by $7 million of higher premiums in 2024 from newly implemented in-force rate actions.
Net investment income increased largely due to higher income from limited partnerships in 2024.
For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”
90
Table of Contents
Benefits and expenses
Benefits and other changes in policy reserves decreased primarily due to lower net premiums collected resulting from benefit reduction elections made by policyholders in connection with our in-force rate actions and legal settlements and from policy terminations. This was partially offset by aging of the in-force block, including higher interest accretion, and higher loss adjustment expenses in 2024.
The liability remeasurement loss in 2024 was largely due to adverse actual versus expected experience primarily driven by lower terminations and higher claims. This was partially offset by net favorable cash flow assumption updates primarily related to approval amounts and implementation timing of our in-force rate action plan and a favorable update to our short-term incidence assumption for IBNR claims. The liability remeasurement loss in 2023 was largely driven by adverse actual variances from expected experience primarily related to higher claims and unfavorable timing impacts from the second legal settlement. In addition, cash flow assumption updates were unfavorable in 2023. See “ —Critical Accounting Estimates—Liability for future policy benefits—Long-term care insurance” for a discussion of the fourth quarter annual review of assumptions.
Acquisition and operating expenses, net of deferrals, decreased principally from $28 million of net insurance recoveries in 2024 related to previously incurred legal settlement expenses, as well as a $13 million accrual for legal settlement costs in 2023 that did not recur. These decreases were partially offset by higher employee-related expenses in 2024.
Provision (benefit) for income taxes. The tax provision in 2024 was primarily attributable to tax expense on certain forward starting swap gains that are tax effected at the previously enacted federal income tax rate of 35% as they are amortized into net investment income, partially offset by a tax benefit related to the pre-tax loss. The tax benefit in 2023 was primarily related to the pre-tax loss, partially offset by tax expense on certain forward starting swap gains.
Long-Term Care Insurance selected operating performance measures
Liability remeasurement (gains) losses
We include expectations for benefit reductions related to in-force rate actions and legal settlements as well as cash payments made to policyholders who elect certain reduced benefit options in connection with the legal settlements, referred to as settlement payments, in our assumptions for the liability for future policy benefits, which have impacted and will continue to impact our reported U.S. GAAP financial results. We update the net premium ratio quarterly for actual variances from expected experience; therefore, forecasted cash flow assumptions will be replaced with actual cash flows each quarter with any difference recorded in net income (loss). As a result, variances between actual experience and our expectations for benefit reductions will be reflected in liability remeasurement (gains) losses in our operating results on a quarterly basis.
The following table sets forth the pre-tax components of the liability remeasurement (gains) losses, net of reinsurance, for the periods indicated:
| (Increase) decrease and | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Years ended December 31 | percentage change | |||||||||||||||||||
| (Amounts in millions) | 2024 | 2023 | 2022 | 2024 vs. 2023 | ||||||||||||||||
| Cash flow assumption updates | $ | (69 | ) | $ | 52 | $ | (335 | ) | $ | (121 | ) | NM | (1) | |||||||
| Actual variances from expected experience | 241 | 269 | 18 | (28 | ) | (10 | )% | |||||||||||||
| Total liability remeasurement (gains) losses | $ | 172 | $ | 321 | $ | (317 | ) | $ | (149 | ) | (46 | )% |
| Column 1 | Column 2 |
|---|---|
| (1) | We define “NM” as not meaningful for increases or decreases greater than 200%. |
For additional discussion of liability remeasurement (gains) losses, see the comparison for this line item above.
91
Table of Contents
In-force rate actions
As part of our strategy for our long-term care insurance business, we have been implementing, and expect to continue to pursue, significant premium rate increases and associated benefit reductions in order to maintain the self-sustainability of our legacy U.S. life insurance subsidiaries and reduce the strain on earnings and capital.
Management regularly monitors and reports in-force rate actions, including state filing approvals; impacted in-force premiums; weighted-average percentage rate increases approved; and gross incremental premiums approved in our Long-Term Care Insurance segment. We also estimate the cumulative economic benefit of approved rate actions in our long-term care insurance multi-year in-force rate action plan on a net present value basis, discounted at our investment portfolio yield. This is based on current assumptions and is defined as the net present value of historical and future expected premium increases and benefit reductions as a result of rate increases approved on individual and group long-term care insurance policies. It also includes the net present value of reserve reductions related to legal settlements less settlement payments. We monitor these selected operating performance measures for in-force rate actions to track our progress on maintaining the self-sustainability of our legacy U.S. life insurance subsidiaries. We consider these in-force rate action metrics to be measures of financial performance and help to enhance the understanding of the operating performance of our Long-Term Care Insurance segment.
The following table sets forth filing approvals as part of our multi-year in-force rate action plan for the years ended December 31:
| (Dollar amounts in millions) | 2024 | 2023 | 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| State filings approved | 97 | 117 | 139 | |||||||||
| Impacted in-force premiums | $ | 870 | $ | 697 | $ | 1,143 | ||||||
| Weighted-average percentage rate increase approved | 39 | % | 51 | % | 48 | % | ||||||
| Gross incremental premiums approved | $ | 343 | $ | 354 | $ | 549 |
We estimate that the cumulative economic benefit of approved rate actions in our multi-year in-force rate action plan from 2012 through December 31, 2024 was approximately $31.2 billion, on a net present value basis, based on our current updated assumptions regarding future premiums and benefit reductions from approved rate actions. This represents a significant increase in estimated rate actions achieved since December 31, 2023, including $2.1 billion of value from rate action approvals and legal settlement implementations in 2024 and an increase of $1.1 billion in the value of benefit reductions connected with our previously achieved rate actions and legal settlements from the impact of our assumption updates.
During the year ended December 31, 2024, we also submitted 90 new filings on approximately $525 million in annualized in-force premiums. The total in-force premiums submitted in 2024 were lower than previous years due to past successes in achieving approvals. In some cases, we received large approvals that either materially completed the current multi-year rate action plan, which removed the need to re-file in the near-term, or resulted in multi-year implementations, which delayed the expected submission of a subsequent filing to beyond 2024.
The approval process for in-force rate actions and the amount and timing of the premium rate increases and associated benefit reductions approved vary by state and product. In certain states, the decision to approve or disapprove a rate increase can take a significant amount of time, and the approved amount may be phased in over time. After approval, insureds are provided with written notice of the increase, and increases are generally applied on the insured’s next policy anniversary date. As a result, the benefits of any rate increase are not fully realized until the implementation cycle is complete and are, therefore, expected to be realized over time.
We continue to work closely with the NAIC and state regulators to demonstrate the broad-based need for actuarially justified rate increases in order to pay future claims. Because obtaining actuarially justified rate increases and associated benefit reductions is important to our ability to pay future claims, we will consider
92
Table of Contents
litigation against states that decline to approve those actuarially justified rate increases. As of December 31, 2024, we were in litigation with two states that have refused to approve actuarially justified rate increases for certain products.
Life and Annuities segment
Trends and conditions
Many factors can affect the results of our life insurance and annuity products, as further discussed below. Because these factors are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. We will continue to monitor our experience and assumptions closely and make changes to our assumptions and methodologies, as appropriate, for our life insurance and annuity products. Even small changes in assumptions or small deviations of actual experience from assumptions could have, and in the past have had, material impacts on our reserve levels, results of operations and financial condition. Results of our life insurance and annuity products depend significantly upon the extent to which our actual future experience is consistent with assumptions and methodologies we have used in calculating our reserves.
Results of our life insurance and annuity products are also impacted by interest rates. For a discussion of the potential impacts and risks associated with changes in interest rates, see “Item 1A—Risk Factors—Interest rates and changes in rates could materially adversely affect our business and profitability.”
We no longer solicit sales of traditional life insurance and annuity products; however, we continue to service our existing retained and reinsured blocks of business.
Life insurance
Results of our life insurance products are impacted primarily by mortality, persistency, investment yields, expenses, reinsurance and statutory reserve requirements, among other factors.
Mortality levels may deviate each period from historical trends. Overall mortality experience during 2024 was largely consistent with 2023. We have experienced unfavorable mortality compared to our then-current and priced-for assumptions in recent years for our universal life insurance block. Reinsurance costs typically increase due to natural aging of the yearly renewable term reinsured blocks. We have also received some yearly renewable term reinsurance premium increases from some of our reinsurance partners that reflect unfavorable mortality.
In the fourth quarter of 2024, our universal life insurance products had an unfavorable pre-tax impact of $28 million from cash flow assumption updates reflecting unfavorable updates to mortality assumptions for contracts originating from term life insurance conversions and interest rate assumptions given the recent rate environment. Consistent with our long-term care insurance business, our 2024 assumption review considered trends during the pandemic years, but updates to our long-term assumptions generally exclude or adjust experience data after 2019, as we do not have sufficient information around the long-term effects of COVID-19.
Certain of our universal life insurance products with secondary guarantees are subject to additional reserves on a statutory basis using regulatory prescribed assumptions, including mortality improvement and the reinvestment rate, which is measured from July to June each year and increased from July 2023 to June 2024. The benefits from the reinvestment rate and mortality improvement more than offset negative assumption updates in these products from a statutory income perspective.
93
Table of Contents
Fixed annuities
Results of our fixed annuity products are affected primarily by investment performance, interest rate levels, the slope of the interest rate yield curve, net interest spreads, equity market conditions, mortality, persistency and expense and commission levels.
We monitor and change crediting rates on fixed deferred annuities on a regular basis to maintain spreads and targeted returns, if applicable. However, we have seen and could continue to see declines in our fixed annuity spreads and margins as interest rates change, depending on the severity of the change.
For fixed indexed annuities, equity market and interest rate performance and volatility could also result in additional gains or losses, although associated hedging activities are expected to partially mitigate these impacts.
In the fourth quarter of 2024, we had an unfavorable pre-tax impact of $16 million from assumption updates primarily related to our fixed indexed annuity lapse assumptions.
Variable annuities
Results of our variable annuity products are affected primarily by investment performance, interest rate levels, the slope of the interest rate yield curve, net interest spreads, equity market conditions, mortality, surrenders and scheduled maturities. In addition, the results of our variable annuity products can significantly impact our regulatory capital requirements and liquidity. We use hedging strategies as well as liquidity planning and asset-liability management to help mitigate these impacts. In addition, we have used reinsurance to help mitigate volatility in our variable annuity results.
Equity market volatility and interest rate movements have caused fluctuations in the results of our variable annuity products and regulatory capital requirements. In the future, equity market and interest rate performance and volatility could result in additional gains or losses in these products, although associated hedging activities are expected to partially mitigate these impacts.
In the fourth quarter of 2024, our variable annuity products had an unfavorable pre-tax impact of $6 million from an update to our lapse assumptions.
94
Table of Contents
Segment results of operations
The following table sets forth the results of operations relating to our Life and Annuities segment for the periods indicated:
| Increase (decrease) and | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Years ended December 31, | percentage change | |||||||||||||||||||
| (Amounts in millions) | 2024 | 2023 | 2022 | 2024 vs. 2023 | ||||||||||||||||
| Revenues: | ||||||||||||||||||||
| Premiums | $ | 179 | $ | 207 | $ | 234 | $ | (28 | ) | (14 | )% | |||||||||
| Net investment income | 959 | 1,042 | 1,083 | (83 | ) | (8 | )% | |||||||||||||
| Net investment gains (losses) | (20 | ) | (49 | ) | (4 | ) | 29 | 59 | % | |||||||||||
| Policy fees and other income | 638 | 646 | 669 | (8 | ) | (1 | )% | |||||||||||||
| Total revenues | 1,756 | 1,846 | 1,982 | (90 | ) | (5 | )% | |||||||||||||
| Benefits and expenses: | ||||||||||||||||||||
| Benefits and other changes in policy reserves | 962 | 963 | 620 | (1 | ) | — | % | |||||||||||||
| Liability remeasurement (gains) losses | (19 | ) | 266 | 27 | (285 | ) | (107 | )% | ||||||||||||
| Changes in fair value of market risk benefits and associated hedges | (13 | ) | (12 | ) | (104 | ) | (1 | ) | (8 | )% | ||||||||||
| Interest credited | 453 | 503 | 504 | (50 | ) | (10 | )% | |||||||||||||
| Acquisition and operating expenses, net of deferrals | 235 | 213 | 604 | 22 | 10 | % | ||||||||||||||
| Amortization of deferred acquisition costs and intangibles | 166 | 181 | 240 | (15 | ) | (8 | )% | |||||||||||||
| Total benefits and expenses | 1,784 | 2,114 | 1,891 | (330 | ) | (16 | )% | |||||||||||||
| Income (loss) from continuing operations before income taxes | (28 | ) | (268 | ) | 91 | 240 | 90 | % | ||||||||||||
| Provision (benefit) for income taxes | (8 | ) | (59 | ) | 16 | 51 | 86 | % | ||||||||||||
| Income (loss) from continuing operations | (20 | ) | (209 | ) | 75 | 189 | 90 | % | ||||||||||||
| Adjustments to income (loss) from continuing operations: | ||||||||||||||||||||
| Net investment (gains) losses | 20 | 49 | 4 | (29 | ) | (59 | )% | |||||||||||||
| Changes in fair value of market risk benefits attributable to interest rates, equity markets and associated hedges(1) | (43 | ) | (22 | ) | (142 | ) | (21 | ) | (95 | )% | ||||||||||
| Expenses related to restructuring | — | — | (1 | ) | — | — | % | |||||||||||||
| Pension plan termination costs | — | — | 8 | — | — | % | ||||||||||||||
| Taxes on adjustments | 5 | (6 | ) | 28 | 11 | 183 | % | |||||||||||||
| Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders | $ | (38 | ) | $ | (188 | ) | $ | (28 | ) | $ | 150 | 80 | % |
| Column 1 | Column 2 |
|---|---|
| (1) | For the years ended December 31, 2024, 2023 and 2022, changes in fair value of market risk benefits and associated hedges were adjusted to exclude changes in reserves, attributed fees and benefit payments of $(30) million, $(10) million and $(38) million, respectively. |
95
Table of Contents
The following table sets forth adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders for the products included in our Life and Annuities segment for the periods indicated:
| Increase (decrease) and | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Years ended December 31, | percentage change | |||||||||||||||||||
| (Amounts in millions) | 2024 | 2023 | 2022 | 2024 vs. 2023 | ||||||||||||||||
| Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders: | ||||||||||||||||||||
| Life insurance | $ | (94 | ) | $ | (275 | ) | $ | (111 | ) | $ | 181 | 66 | % | |||||||
| Fixed annuities | 30 | 50 | 62 | (20 | ) | (40 | )% | |||||||||||||
| Variable annuities | 26 | 37 | 21 | (11 | ) | (30 | )% | |||||||||||||
| Total adjusted operating loss available to Genworth Financial, Inc.’s common stockholders | $ | (38 | ) | $ | (188 | ) | $ | (28 | ) | $ | 150 | 80 | % |
2024 compared to 2023
Adjusted operating income (loss) available to Genworth Financial, Inc.’s common stockholders
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | The adjusted operating loss in our life insurance products decreased primarily from liability remeasurement gains in 2024 compared to losses in 2023, partially offset by lower premiums and a less favorable change in reserves in 2024 in our term life insurance products related to block runoff. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Adjusted operating income in our fixed annuity products decreased mainly from unfavorable assumption updates of $9 million primarily related to our fixed indexed annuity lapse assumptions in 2024, as well as lower net spreads primarily related to block runoff. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Adjusted operating income in our variable annuity products decreased largely from an unfavorable lapse assumption update of $5 million in 2024 compared to favorable assumption updates in 2023. |
Revenues
Premiums. The decrease was driven by our life insurance products largely due to the continued runoff of our in-force blocks.
Net investment income
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Our fixed and variable annuity products decreased $39 million and $6 million, respectively, primarily attributable to lower average invested assets in 2024 driven mostly by block runoff. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Our life insurance products decreased $38 million largely from lower policy loan rates in our corporate-owned life insurance products in 2024. |
Net investment gains (losses). For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”
Benefits and expenses
Benefits and other changes in policy reserves
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Our fixed annuity products decreased $12 million largely attributable to block runoff. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Our variable annuity products decreased $10 million largely from higher reserve releases in 2024. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Our life insurance products increased $21 million primarily from a less favorable change in reserves in our term life insurance products in 2024 related to block runoff and a favorable flooring adjustment in 2023 that did not recur. These increases were partially offset by an increase in cost of reinsurance reserves related to a ceded reinsurance transaction in 2023 that did not recur. |
96
Table of Contents
Liability remeasurement (gains) losses. The favorable variance was mainly driven by a gain in 2024 compared to a loss in 2023 primarily driven by our life insurance products. The liability remeasurement gain in 2024 was primarily due to a $58 million model refinement related to certain universal life insurance products with secondary guarantees, partially offset by $28 million of unfavorable updates to our mortality assumptions for universal life insurance contracts and our interest rate assumptions. The liability remeasurement loss in our life insurance products in 2023 was principally driven by unfavorable updates of $256 million primarily related to our persistency assumptions for certain universal life insurance products with secondary guarantees and unfavorable mortality updates, including more modest mortality improvement. The unfavorable updates in 2023 were partially offset by net favorable impacts related to a ceded reinsurance transaction.
Changes in fair value of market risk benefits and associated hedges. The higher gain in 2024 was primarily attributable to favorable interest rate impacts, partially offset by unfavorable updates to our lapse assumptions of $13 million in our fixed indexed annuity products and $6 million in our variable annuity products compared to favorable assumption updates in 2023. Our variable annuity products also included higher derivative losses in 2024.
Interest credited
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Our life insurance products decreased $37 million primarily driven by lower policy loan rates in our corporate-owned life insurance products in 2024. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Our fixed annuity products decreased $13 million largely due to block runoff, partially offset by higher crediting rates in 2024. |
Acquisition and operating expenses, net of deferrals. The increase was primarily driven by higher operating costs in our life insurance and fixed annuity products and a $5 million legal settlement accrual in 2024.
Amortization of deferred acquisition costs and intangibles. The decrease was largely due to block runoff in our term life insurance products.
Provision (benefit) for income taxes. The effective tax rate was 27.4% and 22.1% for the years ended December 31, 2024 and 2023, respectively. The increase in the effective tax rate was primarily attributable to tax benefits from tax favored items in relation to a lower pre-tax loss in 2024.
Life and Annuities selected operating performance measures
Liability remeasurement (gains) losses
The following table sets forth the pre-tax components of the liability remeasurement (gains) losses, net of reinsurance, for the periods indicated:
| (Increase) decrease and | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Years ended December 31, | percentage change | |||||||||||||||||||
| (Amounts in millions) | 2024 | 2023 | 2022 | 2024 vs. 2023 | ||||||||||||||||
| Cash flow assumption updates | $ | 27 | $ | 256 | $ | (37 | ) | $ | (229 | ) | (89 | )% | ||||||||
| Actual variances from expected experience | (46 | ) | 10 | 64 | (56 | ) | NM | (1) | ||||||||||||
| Total liability remeasurement (gains) losses | $ | (19 | ) | $ | 266 | $ | 27 | $ | (285 | ) | (107 | )% |
| Column 1 | Column 2 |
|---|---|
| (1) | We define “NM” as not meaningful for increases or decreases greater than 200%. |
For additional discussion of liability remeasurement (gains) losses, see the comparison for this line item above.
97
Table of Contents
Life insurance
The following table sets forth insurance in-force for our life insurance products as of the dates indicated:
| Years ended December 31, | Increase (decrease) and percentage change | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (Amounts in millions) | 2024 | 2023 | 2022 | 2024 vs. 2023 | |||||||||||||||
| Term and whole life insurance | |||||||||||||||||||
| Life insurance in-force, net of reinsurance | $ | 41,386 | $ | 44,121 | $ | 48,162 | $ | (2,735 | ) | (6)% | |||||||||
| Life insurance in-force, before reinsurance | $ | 238,865 | $ | 270,950 | $ | 300,145 | $ | (32,085 | ) | (12)% | |||||||||
| Term universal life insurance | |||||||||||||||||||
| Life insurance in-force, net of reinsurance | $ | 88,700 | $ | 90,427 | $ | 92,719 | $ | (1,727 | ) | (2)% | |||||||||
| Life insurance in-force, before reinsurance | $ | 89,283 | $ | 91,024 | $ | 93,336 | $ | (1,741 | ) | (2)% | |||||||||
| Universal life insurance | |||||||||||||||||||
| Life insurance in-force, net of reinsurance | $ | 27,228 | $ | 28,710 | $ | 29,798 | $ | (1,482 | ) | (5)% | |||||||||
| Life insurance in-force, before reinsurance | $ | 30,583 | $ | 32,199 | $ | 33,622 | $ | (1,616 | ) | (5)% |
The decrease in insurance in-force in our life insurance products reflects the continued runoff of our in-force blocks.
Corporate and Other
Results of operations
The following table sets forth the results of operations relating to Corporate and Other for the periods indicated:
| Increase (decrease) and | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Years ended December 31, | percentage change | |||||||||||||||||||
| (Amounts in millions) | 2024 | 2023 | 2022 | 2024 vs. 2023 | ||||||||||||||||
| Revenues: | ||||||||||||||||||||
| Premiums | $ | 11 | $ | 9 | $ | 6 | $ | 2 | 22 | % | ||||||||||
| Net investment income | 21 | 19 | 8 | 2 | 11 | % | ||||||||||||||
| Net investment gains (losses) | (11 | ) | (28 | ) | (15 | ) | 17 | 61 | % | |||||||||||
| Policy fees and other income | — | (2 | ) | — | 2 | 100 | % | |||||||||||||
| Total revenues | 21 | (2 | ) | (1 | ) | 23 | NM | (1) | ||||||||||||
| Benefits and expenses: | ||||||||||||||||||||
| Benefits and other changes in policy reserves | (9 | ) | (9 | ) | (11 | ) | — | — | % | |||||||||||
| Acquisition and operating expenses, net of deferrals | 95 | 65 | 41 | 30 | 46 | % | ||||||||||||||
| Amortization of deferred acquisition costs and intangibles | 4 | 1 | — | 3 | NM | (1) | ||||||||||||||
| Interest expense | 64 | 66 | 54 | (2 | ) | (3 | )% | |||||||||||||
| Total benefits and expenses | 154 | 123 | 84 | 31 | 25 | % | ||||||||||||||
| Loss from continuing operations before income taxes | (133 | ) | (125 | ) | (85 | ) | (8 | ) | (6 | )% | ||||||||||
| Benefit for income taxes | (27 | ) | (20 | ) | (16 | ) | (7 | ) | (35 | )% | ||||||||||
| Loss from continuing operations | (106 | ) | (105 | ) | (69 | ) | (1 | ) | (1 | )% | ||||||||||
| Adjustments to loss from continuing operations: | ||||||||||||||||||||
| Net investment (gains) losses | 11 | 28 | 15 | (17 | ) | (61 | )% | |||||||||||||
| (Gains) losses on early extinguishment of debt | (7 | ) | (2 | ) | 6 | (5 | ) | NM | (1) | |||||||||||
| Expenses related to restructuring | 7 | 4 | 1 | 3 | 75 | % | ||||||||||||||
| Taxes on adjustments | (3 | ) | (6 | ) | (5 | ) | 3 | 50 | % | |||||||||||
| Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders | $ | (98 | ) | $ | (81 | ) | $ | (52 | ) | $ | (17 | ) | (21 | )% |
| Column 1 | Column 2 |
|---|---|
| (1) | We define “NM” as not meaningful for increases or decreases greater than 200%. |
98
Table of Contents
2024 compared to 2023
Adjusted operating loss available to Genworth Financial, Inc.’s common stockholders
The adjusted operating loss increased primarily from higher expenses related to CareScout growth initiatives, partially offset by a higher benefit for income taxes in 2024.
Revenues
For a discussion of the change in net investment gains (losses), see the comparison for this line item under “—Investments and Derivative Instruments.”
Benefits and expenses
Acquisition and operating expenses, net of deferrals, increased primarily from higher expenses related to CareScout growth initiatives, as well as higher employee-related expenses. These increases were partially offset by $5 million of higher gains in 2024 related to the repurchase of Genworth Holdings’ debt.
Amortization of DAC and intangibles in 2024 primarily relates to amortization of capitalized software.
The increase in the benefit for income taxes was primarily related to a higher pre-tax loss, favorable provision to return adjustments and lower terminations of share-based awards in 2024.
Investments and Derivative Instruments
Trends and conditions
Investments
During the year ended December 31, 2024, our investment portfolio was impacted, and we believe will continue to be impacted, by the following macroeconomic trends:
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | The U.S. Federal Reserve decreased the federal funds rate by 100 basis points in 2024 and continues to monitor inflation and labor market conditions, which will influence its plan for additional changes to interest rates in 2025. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | During the fourth quarter of 2024, U.S. Treasury yields increased compared to both September 30, 2024 and December 31, 2023. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Credit spreads tightened during the fourth quarter of 2024 as credit fundamentals remained strong amidst an optimistic macroeconomic backdrop; however, future uncertainty remains as economic policies shift and international trade evolves. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | While our investment portfolio has exposure to the State of California, we have limited exposure to the areas impacted by the January 2025 Los Angeles wildfires. Therefore, we do not expect a material impact on our results of operations, nor do we believe there is a material risk to the valuation of our investment portfolio. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | As of December 31, 2024, our investment portfolio exposure to Israel was immaterial and there has been no impact on our results of operations from the Israel-Hamas conflict. At this time, we do not believe there is a material risk to the valuation of our investment portfolio due to credit losses or direct write-offs that may arise as a result of the conflict. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | As of December 31, 2024, our fixed maturity securities portfolio, which was 97% investment grade, comprised 75% of our total invested assets and cash. |
99
Table of Contents
Derivatives
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | As of December 31, 2024, $1.1 billion notional of our derivatives portfolio was cleared through the Chicago Mercantile Exchange (“CME”). |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | The customer swap agreements that govern our cleared derivatives contain provisions that enable our clearing agents to request initial margin in excess of CME requirements. As of December 31, 2024, we posted initial margin of $74 million to our clearing agents, which represented $37 million more than was otherwise required by the clearinghouse. Because our clearing agents serve as guarantors of our obligations to the CME, the customer agreements contain broad termination provisions that are not specifically dependent on ratings. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | As of December 31, 2024, $12.6 billion notional of our derivatives portfolio was in bilateral OTC derivative transactions pursuant to which we have posted aggregate independent amounts of $554 million and are holding collateral from counterparties in the amount of $11 million. |
Investment results
The following table sets forth information about investment income, excluding net investment gains (losses), for each component of our investment portfolio for the years ended December 31:
| Increase (decrease) | ||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 2023 | 2022 | 2024 vs. 2023 | |||||||||||||||||||||||||||||
| (Amounts in millions) | Yield | Amount | Yield | Amount | Yield | Amount | Yield | Amount | ||||||||||||||||||||||||
| Fixed maturity securities—taxable | 4.6 | % | $ | 2,238 | 4.5 | % | $ | 2,244 | 4.5 | % | $ | 2,296 | 0.1 | % | $ | (6 | ) | |||||||||||||||
| Fixed maturity securities—non-taxable | 5.7 | % | 2 | 4.2 | % | 3 | 4.7 | % | 5 | 1.5 | % | (1 | ) | |||||||||||||||||||
| Equity securities | 2.9 | % | 13 | 3.0 | % | 11 | 4.0 | % | 10 | (0.1 | )% | 2 | ||||||||||||||||||||
| Commercial mortgage loans | 4.5 | % | 297 | 4.4 | % | 302 | 4.6 | % | 321 | 0.1 | % | (5 | ) | |||||||||||||||||||
| Policy loans | 8.3 | % | 189 | 10.2 | % | 224 | 10.0 | % | 211 | (1.9 | )% | (35 | ) | |||||||||||||||||||
| Limited partnerships (1) | 5.1 | % | 152 | 4.5 | % | 117 | 4.7 | % | 99 | 0.6 | % | 35 | ||||||||||||||||||||
| Other invested assets (2) | 45.7 | % | 270 | 50.5 | % | 279 | 59.9 | % | 267 | (4.8 | )% | (9 | ) | |||||||||||||||||||
| Cash, cash equivalents, restricted cash and short-term investments | 4.8 | % | 99 | 4.7 | % | 95 | 1.2 | % | 20 | 0.1 | % | 4 | ||||||||||||||||||||
| Gross investment income before expenses and fees | 5.1 | % | 3,260 | 5.1 | % | 3,275 | 5.0 | % | 3,229 | — | % | (15 | ) | |||||||||||||||||||
| Expenses and fees | (0.2 | )% | (100 | ) | (0.2 | )% | (92 | ) | (0.2 | )% | (83 | ) | — | % | (8 | ) | ||||||||||||||||
| Net investment income | 4.9 | % | $ | 3,160 | 4.9 | % | $ | 3,183 | 4.8 | % | $ | 3,146 | — | % | $ | (23 | ) | |||||||||||||||
| Average invested assets and cash | $ | 64,055 | $ | 64,637 | $ | 65,160 | $ | (582 | ) |
| Column 1 | Column 2 |
|---|---|
| (1) | Limited partnership investments are primarily equity-based and do not have fixed returns by period. |
| Column 1 | Column 2 |
|---|---|
| (2) | Investment income for other invested assets includes amortization of terminated cash flow hedges, which have no corresponding book value within the yield calculation. |
Yields are based on net investment income as reported under U.S. GAAP and are consistent with how we measure our investment performance for management purposes. Yields are annualized, for interim periods, and are calculated as net investment income as a percentage of average quarterly asset carrying values except for fixed maturity securities, derivatives and derivative counterparty collateral, which exclude unrealized fair value adjustments.
Gross annualized weighted-average investment yields were unchanged for 2024 compared to 2023 due to lower average invested assets in 2024. Net investment income decreased largely from lower yields on a large block of policy loans in our corporate-owned life insurance products and lower amortization on interest rate swaps, partially offset by higher income from limited partnerships in 2024.
100
Table of Contents
The following table sets forth net investment gains (losses) for the years ended December 31:
| (Amounts in millions) | 2024 | 2023 | 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Realized investment gains (losses): | ||||||||||||
| Available-for-sale fixed maturity securities: | ||||||||||||
| Realized gains | $ | 49 | $ | 29 | $ | 28 | ||||||
| Realized losses | (106 | ) | (154 | ) | (102 | ) | ||||||
| Net realized gains (losses) on available-for-sale fixed maturity securities | (57 | ) | (125 | ) | (74 | ) | ||||||
| Net realized gains (losses) on equity securities sold | 9 | (1 | ) | — | ||||||||
| Total net realized investment gains (losses) | (48 | ) | (126 | ) | (74 | ) | ||||||
| Net change in allowance for credit losses on available-for-sale fixed maturity securities | (3 | ) | (7 | ) | — | |||||||
| Write-down of available-for-sale fixed maturity securities | (9 | ) | (1 | ) | (2 | ) | ||||||
| Net unrealized gains (losses) on equity securities still held | 83 | 53 | (35 | ) | ||||||||
| Net unrealized gains (losses) on limited partnerships | 43 | 111 | 71 | |||||||||
| Commercial mortgage loans | (16 | ) | (5 | ) | 4 | |||||||
| Derivative instruments | (18 | ) | 7 | 32 | ||||||||
| Other | (19 | ) | (9 | ) | 2 | |||||||
| Net investment gains (losses) | $ | 13 | $ | 23 | $ | (2 | ) |
2024 compared to 2023
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | We recorded $68 million of lower net realized losses related to the sale of available-for-sale fixed maturity securities in 2024. The net losses in 2023 were primarily from sales related to portfolio repositioning and liquidity management, as well as reducing regional bank exposure, including a $15 million loss related to the sale of First Republic Bank U.S. corporate bonds. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | We recorded $30 million of higher net unrealized gains on equity securities driven by more favorable equity market performance in 2024. We also recorded $68 million of lower net unrealized gains on limited partnerships driven by less favorable private equity market performance in 2024. During 2024, we increased the provision for credit losses for both commercial mortgage loans and bank loan investments as a result of annual updates to underlying metrics included in the analytical models used to determine the adequacy of the allowance for credit losses, as well as updates to certain assumptions for bank loan investments. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | We had $18 million of net investment losses related to derivatives in 2024 compared to $7 million of net investments gains in 2023 primarily attributable to higher losses on forward bond purchase commitments driven by an increase in interest rates compared to contracted notional interest rates, higher losses on hedging programs that support our fixed indexed annuity products and lower gains on hedging programs that support our indexed universal life insurance products. |
101
Table of Contents
Investment portfolio
The following table sets forth our cash, cash equivalents and invested assets as of December 31:
| 2024 | 2023 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (Amounts in millions) | Carrying value | % of total | Carrying value | % of total | ||||||||||||
| Available-for-sale fixed maturity securities: | ||||||||||||||||
| Public | $ | 30,650 | 51 | % | $ | 32,189 | 51 | % | ||||||||
| Private | 14,252 | 24 | 14,592 | 24 | ||||||||||||
| Equity securities | 515 | 1 | 396 | 1 | ||||||||||||
| Commercial mortgage loans, net | 6,411 | 11 | 6,802 | 10 | ||||||||||||
| Policy loans | 2,310 | 4 | 2,220 | 4 | ||||||||||||
| Limited partnerships | 3,142 | 5 | 2,821 | 5 | ||||||||||||
| Other invested assets | 648 | 1 | 731 | 1 | ||||||||||||
| Cash, cash equivalents and restricted cash | 2,048 | 3 | 2,215 | 4 | ||||||||||||
| Total cash, cash equivalents and invested assets | $ | 59,976 | 100 | % | $ | 61,966 | 100 | % |
For a discussion of the change in cash, cash equivalents and invested assets, see the comparison for these line items under “—Consolidated Balance Sheets.” See note 4 to our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to our investment portfolio.
We hold fixed maturity and equity securities, limited partnerships, derivatives, embedded derivatives and certain other financial instruments, which are carried at fair value. Fair value is the price that would be received to sell an asset in an orderly transaction between market participants at the measurement date. As of December 31, 2024, approximately 6% of our investment holdings recorded at fair value was based on significant inputs that were not market observable and were classified as Level 3 measurements. See note 19 to our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to fair value.
102
Table of Contents
The following table presents our public, private and total fixed maturity securities by the Nationally Recognized Statistical Rating Organizations (“NRSRO”) designations and/or equivalent ratings, as well as the percentage, based upon fair value that each designation comprises. Certain fixed maturity securities that are not rated by an NRSRO are shown based upon internally prepared credit evaluations.
| As of December 31, | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (Amounts in millions) | 2024 | 2023 | ||||||||||||||||||||||
| Amortized | Fair | % of | Amortized | Fair | % of | |||||||||||||||||||
| NRSRO designation | cost | value | total | cost | value | total | ||||||||||||||||||
| Public fixed maturity securities | ||||||||||||||||||||||||
| AAA | $ | 2,760 | $ | 2,414 | 8 | % | $ | 2,779 | $ | 2,559 | 8 | % | ||||||||||||
| AA | 6,589 | 5,988 | 20 | 6,461 | 6,170 | 19 | ||||||||||||||||||
| A | 9,058 | 8,537 | 28 | 9,474 | 9,287 | 29 | ||||||||||||||||||
| BBB | 14,270 | 13,208 | 42 | 14,346 | 13,645 | 42 | ||||||||||||||||||
| BB | 521 | 476 | 2 | 518 | 498 | 2 | ||||||||||||||||||
| B | 29 | 27 | — | 32 | 30 | — | ||||||||||||||||||
| CCC and lower | — | — | — | — | — | — | ||||||||||||||||||
| Total public fixed maturity securities | $ | 33,227 | $ | 30,650 | 100 | % | $ | 33,610 | $ | 32,189 | 100 | % | ||||||||||||
| Private fixed maturity securities | ||||||||||||||||||||||||
| AAA | $ | 808 | $ | 777 | 5 | % | $ | 866 | $ | 832 | 6 | % | ||||||||||||
| AA | 1,655 | 1,527 | 11 | 1,574 | 1,477 | 10 | ||||||||||||||||||
| A | 4,409 | 4,015 | 28 | 4,398 | 4,043 | 28 | ||||||||||||||||||
| BBB | 7,564 | 6,948 | 49 | 7,709 | 7,126 | 48 | ||||||||||||||||||
| BB | 904 | 850 | 6 | 1,037 | 975 | 7 | ||||||||||||||||||
| B | 92 | 81 | 1 | 149 | 117 | 1 | ||||||||||||||||||
| CCC and lower | 46 | 39 | — | 7 | 7 | — | ||||||||||||||||||
| Not rated | 15 | 15 | — | 15 | 15 | — | ||||||||||||||||||
| Total private fixed maturity securities | $ | 15,493 | $ | 14,252 | 100 | % | $ | 15,755 | $ | 14,592 | 100 | % | ||||||||||||
| Total fixed maturity securities | ||||||||||||||||||||||||
| AAA | $ | 3,568 | $ | 3,191 | 7 | % | $ | 3,645 | $ | 3,391 | 7 | % | ||||||||||||
| AA | 8,244 | 7,515 | 17 | 8,035 | 7,647 | 16 | ||||||||||||||||||
| A | 13,467 | 12,552 | 28 | 13,872 | 13,330 | 29 | ||||||||||||||||||
| BBB | 21,834 | 20,156 | 45 | 22,055 | 20,771 | 45 | ||||||||||||||||||
| BB | 1,425 | 1,326 | 3 | 1,555 | 1,473 | 3 | ||||||||||||||||||
| B | 121 | 108 | — | 181 | 147 | — | ||||||||||||||||||
| CCC and lower | 46 | 39 | — | 7 | 7 | — | ||||||||||||||||||
| Not rated | 15 | 15 | — | 15 | 15 | — | ||||||||||||||||||
| Total fixed maturity securities | $ | 48,720 | $ | 44,902 | 100 | % | $ | 49,365 | $ | 46,781 | 100 | % |
We invest in privately placed fixed maturity securities to increase diversification and obtain higher yields than can ordinarily be obtained with comparable public market securities. Generally, private placements provide us with protective covenants, call protection features and, where applicable, a higher level of collateral. However, our private placements are not as freely transferable as public securities because of restrictions imposed by federal and state securities laws, the terms of the securities and the characteristics of the private market. Based upon fair value, public fixed maturity securities represented 68% and 69%, respectively, of total fixed maturity securities as of December 31, 2024 and 2023. Private fixed maturity securities represented 32% and 31%, respectively, of total fixed maturity securities as of December 31, 2024 and 2023.
We diversify our corporate securities by industry and issuer. As of December 31, 2024, our combined holdings in the 10 corporate issuers to which we had the greatest exposure was $1.7 billion, which was approximately 3% of our total cash, cash equivalents and invested assets. The exposure to the largest single corporate issuer held as of December 31, 2024 was $274 million, which was less than 1% of our total cash, cash
103
Table of Contents
equivalents and invested assets. See note 4 to our consolidated financial statements under “Part II—Item 8—Financial Statements and Supplementary Data” for additional information on diversification by sector.
Other invested assets
The following table sets forth the carrying values of our other invested assets as of December 31:
| 2024 | 2023 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (Amounts in millions) | Carrying value | % of total | Carrying value | % of total | ||||||||||||
| Bank loan investments | $ | 535 | 82 | % | $ | 529 | 72 | % | ||||||||
| Derivatives | 56 | 9 | 131 | 18 | ||||||||||||
| Short-term investments | 4 | 1 | 27 | 4 | ||||||||||||
| Other investments | 53 | 8 | 44 | 6 | ||||||||||||
| Total other invested assets | $ | 648 | 100 | % | $ | 731 | 100 | % |
Derivatives decreased largely from an increase in current market rates compared to contracted notional interest rates in 2024. Short-term investments decreased from net maturities and sales.
Derivatives
The activity associated with derivative instruments can generally be measured by the change in notional value over the periods presented. However, for fixed indexed annuity and indexed universal life embedded derivatives, the change between periods is best illustrated by the number of policies. The following tables represent activity associated with derivative instruments as of the dates indicated:
| (Notional in millions) | Measurement | December 31, 2023 | Additions | Maturities/ terminations | December 31, 2024 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Derivatives designated as hedges | |||||||||||||||||||
| Cash flow hedges: | |||||||||||||||||||
| Interest rate swaps | Notional | $ | 8,975 | $ | 331 | $ | (549 | ) | $ | 8,757 | |||||||||
| Foreign currency swaps | Notional | 131 | 13 | — | 144 | ||||||||||||||
| Forward bond purchase commitments | Notional | 1,075 | 1,564 | — | 2,639 | ||||||||||||||
| Total cash flow hedges | 10,181 | 1,908 | (549 | ) | 11,540 | ||||||||||||||
| Total derivatives designated as hedges | 10,181 | 1,908 | (549 | ) | 11,540 | ||||||||||||||
| Derivatives not designated as hedges | |||||||||||||||||||
| Equity index options | Notional | 702 | 620 | (718 | ) | 604 | |||||||||||||
| Financial futures | Notional | 1,251 | 4,618 | (4,767 | ) | 1,102 | |||||||||||||
| Forward bond purchase commitments | Notional | 500 | — | — | 500 | ||||||||||||||
| Total derivatives not designated as hedges | 2,453 | 5,238 | (5,485 | ) | 2,206 | ||||||||||||||
| Total derivatives | $ | 12,634 | $ | 7,146 | $ | (6,034 | ) | $ | 13,746 | ||||||||||
| (Number of policies) | Measurement | December 31, 2023 | Additions | Maturities/ terminations | December 31, 2024 | ||||||||||||||
| Derivatives not designated as hedges | |||||||||||||||||||
| Fixed indexed annuity embedded derivatives | Policies | 5,826 | — | (959 | ) | 4,867 | |||||||||||||
| Indexed universal life embedded derivatives | Policies | 749 | — | (32 | ) | 717 |
The increase in the notional value of derivatives was primarily attributable to the addition of forward bond purchase commitments that support our long-term care insurance business and universal life insurance products, partially offset by a decrease in interest rate swaps that support our long-term care insurance business.
104
Table of Contents
The number of policies with embedded derivatives decreased as these products are no longer being offered and continue to runoff.
Critical Accounting Estimates
The accounting estimates and assumptions (including sensitivities) discussed in this section are those that we consider to be critical to an understanding of our consolidated financial statements because their application places significant demands on our ability to judge the effect of inherently uncertain matters on our financial results. For all of these accounting estimates and assumptions (including sensitivities), we caution that future events seldom develop as estimated and management’s best estimates often require adjustment. See “Cautionary Note Regarding Forward-looking Statements.” For a detailed discussion of our significant accounting policies, see note 2 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.”
The sensitivities in the tables below are changes that we consider to be reasonably possible given historical changes in market conditions and our experience with these products. The impacts are discrete and do not reflect the impact one factor may have on another. In any period and over time, our actual experience may have a positive or negative variance from our long-term assumptions, either singularly or collectively, and these variances may offset each other.
Liability for future policy benefits
The measurement of the liability for future policy benefits reflects estimates and actuarial assumptions and methodologies which involve the exercise of significant judgment and are inherently uncertain. Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Establishing assumptions for the liability for future policy benefits is complex and involves many factors. Any future adverse changes in our assumptions would likely result in the establishment of additional future policy benefit reserves with a corresponding loss recognized in net income (loss). Our future financial results depend significantly upon the extent to which our actual future experience is consistent with the assumptions we have used in determining our liability for future policy benefits. Even small changes in assumptions or small deviations of actual experience from assumptions could have, and in the past have had, material impacts on our reserve levels, results of operations and financial condition.
The liability for future policy benefits is equal to the present value of expected future benefits and claim-related expenses, less the present value of expected future net premiums. Cash flow assumptions, as applicable, used to estimate the liability for future policy benefits include health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force from one period to the next), insured mortality (i.e., life expectancy or longevity), insured morbidity (i.e., frequency and severity of claim, including claim termination rates and benefit utilization rates), and estimates of future in-force rate actions, which include premium rate increases and benefit reductions associated with our long-term care insurance products. The liability is measured for each group of contracts, or cohorts, using best estimate cash flow assumptions, which are reviewed at least annually in the fourth quarter or more frequently if actual experience indicates a change is required. The change in the liability for future policy benefits, at the locked-in discount rate, resulting from cash flow assumption updates and variances between actual and expected experience is reflected as liability remeasurement (gains) losses in the consolidated statements of income.
See notes 2 and 8 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to the liability for future policy benefits.
105
Table of Contents
Long-term care insurance
The liability for future policy benefits for our long-term care insurance products is estimated using assumptions related to both insured individuals on claim (disabled life assumptions) and insured individuals not on claim (healthy life assumptions). Key cash flow assumptions used to estimate the liability for future policy benefits include claim termination rates, incidence and benefit utilization rates, mortality, lapse rates and in-force rate actions. Claim termination rates represent the expected rates at which claims end. Incidence rates represent the likelihood the policyholder will go on claim. Benefit utilization rates represent how much of the available policy benefits are expected to be used. In-force rate actions represent the remaining premium rate increases and associated benefit reductions not yet achieved in our long-term care insurance multi-year in-force rate action plan and are based on our best estimate given our current plans for rate increase filings and our historical experience regarding rate increase approvals.
In the fourth quarter of 2024, liability remeasurement gains (losses) within net income included unfavorable cash flow assumption updates of $20 million primarily related to updates to healthy life and near-term benefit utilization assumptions to better align with recent experience, including cost of care inflation. These unfavorable impacts were partially offset by favorable assumption updates for future in-force rate action approvals given our current plans for rate increase filings and our recent experience regarding approvals and regulatory support. The unfavorable impacts were also partially offset by favorable updates to our short-term incidence assumptions for IBNR claims, reducing sufficiency held through a period of heightened uncertainty around incidence during and immediately following COVID-19. While our 2024 assumption review considered trends during the pandemic years, our updates to long-term assumptions generally exclude or adjust experience data after 2019, as we do not have sufficient information around the long-term effects of COVID-19.
In the fourth quarter of 2023, liability remeasurement gains (losses) within net income included unfavorable cash flow assumption updates of $61 million primarily related to updates to our healthy life assumptions to better reflect near-term experience, partially offset by a favorable update to disabled life mortality assumptions to reflect an expectation that mortality will continue at elevated levels in the near term post-COVID-19. Updates also included favorable assumption updates for future in-force rate action approvals and benefit reductions based on recent favorable rate increase approval experience and feedback from regulators, along with the reflection of the third legal settlement, which had a muted favorable income statement impact in the fourth quarter of 2023 because it primarily impacted profitable uncapped cohorts.
A summary of certain of our significant estimates and assumptions used in the calculation of our long-term care insurance liability for future policy benefits, net of reinsurance recoverable, was as follows for the years ended December 31:
| Increase (decrease) and | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| percentage change | ||||||||||||||||
| (Amounts in millions) | 2024 | 2023 | 2024 vs. 2023 | |||||||||||||
| Present value of expected net premiums (1) | $ | 14,720 | $ | 15,333 | $ | (613 | ) | (4) | % | |||||||
| Present value of expected future policy benefits (1) | $ | 50,031 | $ | 50,095 | $ | (64 | ) | — | % |
| Column 1 | Column 2 |
|---|---|
| (1) | At the locked-in discount rate. |
106
Table of Contents
The following sensitivities reflect hypothetical unfavorable changes to certain of our significant estimates and assumptions and the associated impact it would have on liability remeasurement gains (losses) within pre-tax income for the year ended December 31, 2024:
| (Amounts in millions) | ||||
|---|---|---|---|---|
| 5% increase in future claim costs (1) | $ | (1,580 | ) | |
| Decrease in claim termination rates (2) | $ | (300 | ) | |
| 10% decrease in benefit of future in-force rate actions (3) | $ | (160 | ) |
| Column 1 | Column 2 |
|---|---|
| (1) | Reflects the impact of an unfavorable assumption change for claim terminations, incidence or benefit utilization rates (any discrete adverse assumption changes therefrom or in combination with, that results in our future claim costs increasing by 5%). |
| Column 1 | Column 2 |
|---|---|
| (2) | Reflects the impact of a 3% decrease in mortality and 8% decrease in lapse rates. |
| Column 1 | Column 2 |
|---|---|
| (3) | Reflects the impact of an unfavorable change to our assumptions for future premium rate increases and benefit reductions. |
Life insurance
Key cash flow assumptions used to estimate the liability for future policy benefits for our life insurance products include mortality and lapse rates.
In the fourth quarter of 2024, our annual review of cash flow assumptions did not have a significant impact on liability remeasurement gains (losses) within net income for our life insurance products. In the fourth quarter of 2023, liability remeasurement gains (losses) within net income included unfavorable cash flow assumption updates of $56 million primarily as a result of updates to our mortality assumptions, including emerging experience related to more modest mortality improvement and an expectation that mortality will continue at elevated levels in the near-term post-COVID-19.
A summary of certain of our significant estimates used in the calculation of our life insurance liability for future policy benefits, net of reinsurance recoverable, was as follows for the years ended December 31:
| Increase (decrease) and | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| percentage change | ||||||||||||||||
| (Amounts in millions) | 2024 | 2023 | 2024 vs. 2023 | |||||||||||||
| Present value of expected net premiums (1) | $ | 1,612 | $ | 1,835 | $ | (223 | ) | (12 | )% | |||||||
| Present value of expected future policy benefits (1) | $ | 1,816 | $ | 2,192 | $ | (376 | ) | (17 | )% |
| Column 1 | Column 2 |
|---|---|
| (1) | At the locked-in discount rate and excluding the impacts of flooring adjustments. See note 2 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information. |
The following sensitivities reflect hypothetical unfavorable changes to certain of our significant estimates and assumptions and the associated impact it would have on liability remeasurement gains (losses) within pre-tax income for the year ended December 31, 2024:
| (Amounts in millions) | ||||
|---|---|---|---|---|
| 2% increase in mortality | $ | (25 | ) | |
| 10% increase in lapses | $ | (65 | ) |
Fixed annuities
The key cash flow assumption used to estimate the liability for future policy benefits for our fixed annuity products is mortality.
107
Table of Contents
In the fourth quarters of 2024 and 2023, our annual review of cash flow assumptions did not have a significant impact on liability remeasurement gains (losses) within net income for our fixed annuity products.
A summary of certain of our significant estimates and assumptions used in the calculation of our fixed annuities liability for future policy benefits, net of reinsurance recoverable, was as follows for the years ended December 31:
| Increase (decrease) and | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| percentage change | ||||||||||||||||
| (Amounts in millions) | 2024 | 2023 | 2024 vs. 2023 | |||||||||||||
| Total present value of expected future policy benefits (1) | $ | 2,518 | $ | 2,691 | $ | (173 | ) | (6 | )% |
| Column 1 | Column 2 |
|---|---|
| (1) | At the locked-in discount rate. |
A hypothetical decrease of 10% to our mortality assumption would have an unfavorable impact of $60 million on liability remeasurement gains (losses) within pre-tax income for the year ended December 31, 2024.
Policyholder account balances – additional insurance liabilities
The liability for policyholder account balances represents the contract value that has accrued to the benefit of the policyholder as of the balance sheet date for investment-type and universal and term universal life insurance contracts. We are also required to establish additional benefit reserves for guarantees or product features in addition to the contract value where the additional benefit reserves are calculated by applying a benefit ratio to accumulated contractholder assessments, and then deducting accumulated paid claims, commonly referred to as the additional insurance liability. The benefit ratio is equal to the present value of total expected benefit payments over the life of the contract divided by the present value of total expected assessments over the life of the contract, discounted by the projected crediting rate. The assumptions used to calculate the benefit ratio include insured mortality, interest rates and policyholder persistency or lapses, among other assumptions.
We perform an annual review of assumptions for our universal and term universal life insurance products in the fourth quarter. Our 2024 review resulted in an expense recorded to pre-tax income of $28 million largely associated with an unfavorable update to our mortality assumptions for universal life insurance contracts originating from term life insurance conversions and an unfavorable update to interest rate assumptions given the recent rate environment.
Our 2023 review resulted in an expense recorded to pre-tax income of $200 million primarily to reflect unfavorable persistency and mortality assumptions. We made unfavorable updates to our persistency assumptions in our universal life insurance products with secondary guarantees to better reflect emerging experience. We also made unfavorable updates to our mortality assumptions in universal and term universal life insurance products to better reflect emerging experience related to more modest mortality improvement and to include an expectation that mortality will continue at elevated levels in the near term post-COVID-19.
The following sensitivities reflect hypothetical unfavorable changes to certain of our significant estimates and assumptions and the associated impact it would have on liability remeasurement gains (losses) within pre-tax income for the year ended December 31, 2024:
| (Amounts in millions) | ||||
|---|---|---|---|---|
| 100 basis point decrease in projected crediting rates | $ | (36 | ) | |
| 10% decrease in lapses | $ | (226 | ) | |
| 2% increase in mortality | $ | (43 | ) |
108
Table of Contents
Liability for policy and contract claims
The liability for policy and contract claims represents the amount needed to provide for the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the end of the respective reporting period. The estimated liability includes requirements for future payments of: (i) losses that have been reported to the insurer; (ii) losses related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated; and (iii) loss adjustment expenses. Loss adjustment expenses include costs incurred in the claim settlement process such as legal fees and costs to record, process and adjust claims.
Our liability for policy and contract claims is reviewed regularly, with changes in our estimates of future claims recorded through net income (loss).
Mortgage insurance
Estimates and actuarial assumptions used for establishing loss reserves involve the exercise of significant judgment, and changes in assumptions or deviations of actual experience from assumptions can have material impacts on Enact’s loss reserves and net income (loss). Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, Enact cannot determine with precision the ultimate amounts it will pay for actual claims or the timing of those payments. The sources of uncertainty affecting the estimates are numerous and include factors internal and external to Enact. Internal factors include, but are not limited to, changes in the mix of exposures, loss mitigation activities and claim settlement practices. Significant external influences include changes in home prices, unemployment, government housing policies, state foreclosure timelines, general economic conditions, interest rates, tax policy, credit availability and mortgage products. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on Enact’s reserves, results of operations and financial condition.
Enact establishes reserves to recognize the estimated liability for losses and loss adjustment expenses related to defaults on insured mortgage loans. Loss reserves are established by estimating the number of loans in the inventory of delinquent loans that will result in a claim payment, which is referred to as the claim rate, and further estimating the amount of the claim payment, which is referred to as claim severity. The estimates are determined using a factor-based approach, in which assumptions of claim rates for loans in default and the average amount paid for loans that result in a claim are calculated using traditional actuarial techniques. Over time, as the status of the underlying delinquent loans moves toward foreclosure and the likelihood of the associated claim loss increases, the amount of the loss reserves associated with the potential claims may also increase.
Enact’s management monitors actual experience, and where circumstances warrant, will revise its assumptions. The liability for loss reserves is reviewed regularly, with changes in estimates of future claims recorded through net income. Estimation of losses is based on historical claim and cure experience and covered exposures and is inherently judgmental. Future developments may result in losses greater or less than the liability for loss reserves provided.
Enact’s loss reserves were $525 million and $518 million as of December 31, 2024 and 2023, respectively. In considering the potential sensitivity of the factors underlying Enact’s best estimate of its mortgage insurance reserves, it is possible that even a relatively small change in the estimated claim or severity rate could have a significant impact on loss reserves and, correspondingly, on our results of operations. For example, based on Enact’s actual experience during the three-year period ended December 31, 2024, a quarterly change of 4% in its average claim rate would change the gross loss reserve amount for such quarter by approximately $72 million, and a change of 3% in its average severity rate would change the gross loss reserve amount for such quarter by approximately $15 million.
109
Table of Contents
Valuation of fixed maturity securities. Our portfolio of fixed maturity securities comprises primarily investment grade securities, which are carried at fair value.
The methodologies, estimates and assumptions used in valuing our fixed maturity securities evolve over time and are subject to different interpretations, all of which can lead to materially different estimates of fair value. Additionally, because the valuation is based on market conditions at a specific point in time, the period-to-period changes in fair value may vary significantly due to changing interest rates, as well as external macroeconomic and credit market conditions. For example, widening credit spreads will generally result in a decrease, while tightening credit spreads will generally result in an increase, in the fair value of our fixed maturity securities. Additionally, during periods of increasing interest rates, the market values of lower-yielding assets will decline. See “Item 7A—Quantitative and Qualitative Disclosures About Market Risk—Sensitivity Analysis—Interest Rate Risk” for the impact of hypothetical changes in interest rates on our investment portfolio.
Our valuation techniques maximize the use of observable inputs. However, for certain less liquid securities, categorized as Level 3, the valuation inputs and assumptions cannot be corroborated with observable market data and require greater estimation, resulting in values that are less certain. Additionally, the availability of observable market information may change as certain inputs may be more direct drivers of valuation at the time of pricing, or if certain assets previously in active markets become less liquid due to changes in the financial environment. As a result, more securities may be categorized as Level 3 and require more subjectivity and management judgment. As of December 31, 2024, 6% of our total fixed maturity securities related to Level 3 fixed maturity securities valued using internal pricing models. See notes 2, 4 and 19 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information related to the valuation of fixed maturity securities and a description of the fair value measurement estimates and level assignments.
The following tables summarize the primary sources of data considered when determining the fair value of fixed maturity securities as of December 31:
| 2024 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (Amounts in millions) | Total | Level 1 | Level 2 | Level 3 | |||||||||||
| Fixed maturity securities: | |||||||||||||||
| Pricing services | $ | 39,752 | $ | — | $ | 39,752 | $ | — | |||||||
| Broker quotes | 247 | — | — | 247 | |||||||||||
| Internal models | 4,903 | — | 2,357 | 2,546 | |||||||||||
| Total fixed maturity securities | $ | 44,902 | $ | — | $ | 42,109 | $ | 2,793 |
| 2023 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (Amounts in millions) | Total | Level 1 | Level 2 | Level 3 | |||||||||||
| Fixed maturity securities: | |||||||||||||||
| Pricing services | $ | 41,311 | $ | — | $ | 41,311 | $ | — | |||||||
| Broker quotes | 221 | — | — | 221 | |||||||||||
| Internal models | 5,249 | — | 2,374 | 2,875 | |||||||||||
| Total fixed maturity securities | $ | 46,781 | $ | — | $ | 43,685 | $ | 3,096 |
110
Table of Contents
Consolidated Balance Sheets
Total assets. Total assets decreased $3,946 million from $90,817 million as of December 31, 2023 to $86,871 million as of December 31, 2024.
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Invested assets decreased $1,823 million primarily attributable to decreases of $1,879 million in fixed maturity securities and $391 million in commercial mortgage loans, partially offset by an increase of $321 million in limited partnerships. The decrease in fixed maturity securities was predominantly related to higher interest rates decreasing the fair value of our fixed maturity investment portfolio, as well as net sales and maturities in 2024. Commercial mortgage loans decreased mostly due to payments outpacing originations. Limited partnerships increased largely from capital calls in 2024. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Cash and cash equivalents decreased $167 million largely due to net withdrawals from our investment contracts, federal income tax payments and repurchases of Genworth Financial’s common stock, partially offset by net sales and maturities of fixed maturity securities and commercial mortgage loan payments outpacing originations in 2024. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Deferred acquisition costs decreased $209 million largely driven by amortization in our life and long-term care insurance products in 2024. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Reinsurance recoverable decreased $1,370 million primarily due to an increase in the single-A interest rate used to discount the reinsurance recoverable and from the runoff of certain ceded products in 2024. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | The deferred tax asset decreased $234 million principally from the net effect of changes in the discount rate used to measure the liability for future policy benefits and related reinsurance recoverables due to an increase in the single-A interest rate. In addition, we increased our valuation allowance related to deferred tax assets that would produce capital losses by $100 million through accumulated other comprehensive income (loss) in the fourth quarter of 2024. These decreases in the deferred tax asset were partially offset by an increase in net unrealized losses on investments and derivatives due to rising interest rates and an increase related to future annuity and contract benefits in 2024. |
Total liabilities. Total liabilities decreased $5,042 million from $82,482 million as of December 31, 2023 to $77,440 million as of December 31, 2024.
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | The liability for future policy benefits decreased $4,045 million primarily from an increase in the single-A interest rate used to discount the liability for future policy benefits and from the runoff of our fixed annuity and life insurance products. These decreases were partially offset by an increase in our long-term care insurance reserves largely driven by aging of the in-force block, including higher interest accretion, partially offset by benefit payments outpacing premiums collected. The increase in our long-term care insurance reserves also included the effects of changes in cash flow assumptions and actual variances from expected experience. See “—Critical Accounting Estimates—Liability for future policy benefits” for additional information on the impact of changes in cash flow assumptions. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Policyholder account balances decreased $946 million largely driven by surrenders, withdrawals and benefit payments in our fixed annuity and universal and term universal life insurance products in 2024. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Market risk benefit liabilities decreased $160 million mostly related to favorable interest rate changes and equity market performance in 2024. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Other liabilities increased $258 million primarily from higher derivative valuations due to an increase in interest rates in 2024. |
Total equity. Total equity increased $1,096 million from $8,335 million as of December 31, 2023 to $9,431 million as of December 31, 2024.
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | We reported net income available to Genworth Financial, Inc.’s common stockholders of $299 million for the year ended December 31, 2024. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Unrealized gains (losses) on investments and derivatives qualifying as hedges decreased total equity by $1,026 million and $518 million, respectively, primarily due to an increase in interest rates in 2024. |
111
Table of Contents
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Change in the discount rate used to measure future policy benefits increased total equity by $2,462 million largely attributable to an increase in the single-A interest rate used to discount the liability for future policy benefits and the related reinsurance recoverables in 2024. |
| Column 1 | Column 2 | Column 3 | Column 4 |
|---|---|---|---|
| • | Treasury stock increased $188 million due to the repurchase of Genworth Financial’s common stock, at cost, including excise taxes and other associated costs, resulting in a decrease to total equity in 2024. |
Liquidity and Capital Resources
Liquidity and capital resources represent our overall financial strength and our ability to generate cash flows from our businesses, borrow funds at competitive rates and raise new capital to meet our operating and growth needs.
Overview of cash flows—Genworth and subsidiaries
The following table sets forth our condensed consolidated cash flows for the years ended December 31:
| (Amounts in millions) | 2024 | 2023 | 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net cash from operating activities | $ | 88 | $ | 597 | $ | 1,049 | ||||||
| Net cash from investing activities | 861 | 1,261 | 733 | |||||||||
| Net cash used by financing activities | (1,115 | ) | (1,443 | ) | (1,554 | ) | ||||||
| Net increase (decrease) in cash before foreign exchange effect | $ | (166 | ) | $ | 415 | $ | 228 |
Our principal sources of cash include premiums and other payments received on our insurance products and services, income from our investment portfolio and proceeds from sales and maturities of investments. Cash flows related to operating activities are affected by the timing of premiums, fees and investment income received and benefits, claims and expenses paid. Cash flows from operating activities have been invested to support the obligations of our insurance and investment products and required capital supporting these products. In analyzing our cash flows, we focus on the change in the amount of cash available and used in investing activities. Changes in cash from financing activities primarily relate to deposits to, and redemptions and benefit payments on, universal life insurance and investment contracts; the issuance of debt and equity securities; the repayment or repurchase of borrowings; the repurchase of common stock presented as treasury stock; and other capital transactions.
2024 compared to 2023
Net cash inflows from operating activities were lower in 2024 primarily driven by higher benefit payments and lower premiums collected in our long-term care insurance business, as well as higher federal income tax payments. We expect our operating cash flows to continue to be impacted by higher benefit payments and lower premiums collected on our legacy long-term care insurance products as further discussed below in “Regulated insurance subsidiaries.”
Net cash inflows from investing activities were lower in 2024 mainly due to lower net sales and maturities of fixed maturity securities and higher funding of bank loans, partially offset by commercial mortgage loan payments outpacing originations at a higher pace and lower capital calls on limited partnerships.
Net cash outflows related to financing activities were lower in 2024 primarily due to lower net withdrawals from our investment contracts and lower repurchases of Genworth Financial’s common stock, partially offset by higher repurchases of Genworth Holdings’ debt and expenses associated with Enact Holdings’ early debt redemption and issuance of new debt.
112
Table of Contents
Genworth—holding company liquidity
In consideration of our liquidity, it is important to separate the needs of our holding companies from the needs of their respective subsidiaries. Genworth Financial and Genworth Holdings each act as a holding company for their respective subsidiaries and do not have any significant operations of their own. Genworth Financial’s and Genworth Holdings’ principal sources of cash are derived from dividends and other returns of capital from Enact Holdings. Additional sources of cash have included subsidiary payments to them under tax sharing and expense reimbursement arrangements and proceeds from borrowings or securities issuances. The primary uses of funds at Genworth Financial and Genworth Holdings include payments of principal, interest and other expenses on borrowings or other obligations, payment of holding company general operating expenses (including employee benefits and taxes), payments under guarantees (including guarantees of certain subsidiary obligations), payments to subsidiaries (or, in the case of Genworth Holdings, to Genworth Financial) under tax sharing agreements, investments in CareScout, repurchases of debt securities, repurchases of Genworth Financial’s common stock and, in the case of Genworth Holdings, loans, dividends or other distributions to Genworth Financial. For more information on our tax obligations, refer to note 16 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.”
Management’s focus is predominantly on Genworth Holdings’ liquidity given it is the issuer of our outstanding public debt. We manage our legacy U.S. life insurance subsidiaries on a standalone basis and accordingly, do not expect to receive any dividends or other returns of capital from them. Therefore, our liquidity at the holding company level is highly dependent on the performance of Enact Holdings and its ability to pay timely dividends and other forms of capital returns to Genworth Holdings as anticipated. Genworth Financial has the right to appoint a majority of directors to the board of directors of Enact Holdings; however, actions taken by Enact Holdings and its board of directors are subject to and may be limited by the interests of Enact Holdings, including but not limited to, its use of capital for growth opportunities and regulatory requirements. Future dividends will be subject to quarterly review and approval by Enact Holdings’ board of directors and Genworth Financial and will also be dependent on a variety of economic, market and business conditions, among other considerations. In addition, insurance laws and regulations regulate the payment of dividends and other distributions to Genworth Financial and Genworth Holdings by their insurance subsidiaries. See “—Regulated insurance subsidiaries” for additional details.
Enact Holdings’ capital allocation strategy includes supporting its existing policyholders, growing its mortgage insurance business, funding attractive new business opportunities and returning capital to its shareholders. In addition to its quarterly cash dividend program, on August 1, 2023, Enact Holdings announced the approval by its board of directors of a share repurchase program under which Enact Holdings could repurchase up to $100 million of its outstanding common stock. On May 1, 2024, Enact Holdings announced a new share repurchase authorization of $250 million. Genworth Holdings has agreed to participate in order to maintain its overall ownership at approximately its current level. As the majority shareholder, Genworth Holdings received $289 million of capital returns from Enact Holdings in 2024, comprised of quarterly dividends and share repurchases. The timing and number of future shares repurchased under the share repurchase program will depend on a variety of factors, including Enact Holdings’ stock price, capital availability, business and market conditions, regulatory requirements and debt covenant restrictions, among other factors.
On July 31, 2023, Genworth Financial’s Board of Directors authorized an additional $350 million of share repurchases under its existing share repurchase program that began in May 2022. Pursuant to the program, during 2024, Genworth Financial repurchased 28,566,288 shares of its common stock at an average price of $6.52 per share for a total of $186 million, before excise taxes and other associated costs. Genworth Financial also executed repurchases under its share repurchase program in 2025 through a Rule 10b5-1 trading plan under which 2,789,970 shares of its common stock were repurchased through February 20, 2025 at an average price of $7.17 per share, leaving approximately $135 million available for repurchase under the program as of February 20, 2025. Further repurchases under the program will continue to be funded from holding company capital, as well as future cash flow generation, including expected future capital returns from Enact Holdings. Under the program, share repurchases may be made at Genworth’s discretion from time to time in open market transactions, privately negotiated
113
Table of Contents
transactions, or by other means, including through Rule 10b5-1 trading plans. The timing and number of future shares repurchased under the program will depend on a variety of factors, including Genworth Financial’s stock price and trading volume, and general business and market conditions, among other factors. The authorization has no expiration date and may be modified, suspended or terminated at any time.
Our future use of liquidity and capital will prioritize strategic investments in CareScout and returning capital to Genworth Financial’s shareholders through share repurchases. In addition, we also expect to continue to repurchase or redeem outstanding debt from time to time (with cash on hand, proceeds from the issuance of new debt and/or the proceeds from asset or stock sales) in open market purchases, tender offers, privately negotiated transactions or otherwise.
Genworth Holdings had $294 million and $350 million of unrestricted cash and cash equivalents as of December 31, 2024 and 2023, respectively. The decrease was principally driven by repurchases of Genworth Financial’s common stock, as well as interest payments on and repurchases of Genworth Holdings’ debt, partially offset by capital returns from Enact Holdings. The $294 million of Genworth Holdings’ cash and cash equivalents included approximately $186 million of advance cash payments from our subsidiaries held for future obligations, including $75 million for CareScout Insurance to meet the regulatory capital requirements of a new start-up insurer. We do not consider this cash when evaluating holding company liquidity for the purposes of allocating capital or computing our cash position relative to the cash management target discussed below. We believe Genworth Holdings’ unrestricted cash and cash equivalents provide sufficient liquidity to meet its financial obligations over the next twelve months as well as in the longer term. We expect Genworth Holdings’ liquidity to continue to be impacted by the amounts and timing of Genworth Financial’s share repurchases, investments in CareScout, and future dividends and other forms of capital returns from Enact Holdings. In addition, we began paying federal income taxes in 2023, resulting in lower intercompany cash tax payments retained by Genworth Holdings from its subsidiaries in 2024 as compared to the amounts retained during recent prior years. We anticipate lower intercompany cash tax payments to be retained going forward as we utilized our remaining foreign tax credits in 2023.
We actively monitor our liquidity position (most notably at Genworth Holdings), liquidity generation options and the credit markets given changing market conditions. Genworth Holdings’ cash management target is to maintain a cash buffer of two times expected annual external debt interest payments. Genworth Holdings may move below or above this targeted cash buffer during any given quarter due to the timing of cash outflows and inflows or as a result of planned future actions. Management of Genworth Financial continues to evaluate Genworth Holdings’ target level of liquidity as circumstances warrant.
Capital resources and financing activities
Our current capital resource plans do not include any additional debt offerings by Genworth Holdings or minority sales of Enact Holdings. The availability of additional capital resources will depend on a variety of factors such as market conditions, regulatory considerations, the general availability of credit, credit ratings and the performance of and outlook for Enact Holdings and the payment of dividends and other returns of capital therefrom. For a discussion of certain risks associated with our liquidity and dependency on dividends paid by Enact Holdings, see “Item 1A—Risk Factors—Genworth Financial and Genworth Holdings depend on the ability of Enact Holdings and its subsidiaries to pay dividends and make other payments and distributions to each of them to meet their obligations,” and “Item 1A—Risk Factors—Our sources of capital have become more limited, and under certain conditions we may need to seek additional capital on unfavorable terms.”
During 2024 and 2023, Genworth Holdings repurchased $66 million and $32 million, respectively, principal amount of its debt. As of December 31, 2024, Genworth Holdings had $790 million aggregate principal amount of outstanding debt, with no maturities due until June 2034.
In 2024, given the current interest rate environment, Genworth Holdings entered into an interest rate swap designed to hedge the variable interest payments on $100 million aggregate principal amount of its floating rate
114
Table of Contents
junior subordinated notes due in 2066 (“2066 Notes”), locking in an approximate 5.5% fixed interest rate for a period of five years from the hedge origination date.
On May 28, 2024, Enact Holdings issued $750 million aggregate principal amount of unsecured senior notes, maturing on May 28, 2029. The 2029 Notes bear interest at an annual rate of 6.25% payable semi-annually in arrears on May 28 and November 28 of each year, which commenced on November 28, 2024. On June 3, 2024, Enact Holdings redeemed all $750 million aggregate principal amount outstanding of its 2025 Notes for a pre-tax loss of $11 million. Enact Holdings funded the redemption primarily through the net proceeds from the issuance of its 2029 Notes.
For further information about Genworth Holdings’ and Enact Holdings’ borrowings, refer to note 15 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.”
Regulated insurance subsidiaries
Insurance laws and regulations regulate the payment of dividends and other distributions to us by our insurance subsidiaries. See note 20 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data” for additional information regarding the payment of dividends. In general, dividends are required to be submitted to an insurer’s domiciliary department of insurance for review, and distributions from sources other than unassigned surplus require affirmative approval before being paid. Based on estimated statutory results as of December 31, 2024, in accordance with applicable dividend restrictions, Enact Holdings’ U.S. mortgage insurance subsidiaries could pay dividends from unassigned surplus of approximately $153 million in 2025 without affirmative regulatory approval. However, Enact Holdings may choose not to pay dividends in 2025 at this level as it may retain capital for future growth or to meet regulatory or other capital requirements.
Our insurance subsidiaries’ principal cash inflows from operations are derived from premiums, annuity deposits and insurance and investment product fees and other income, including commissions, cost of insurance, mortality, expense and surrender charges, contract underwriting fees, investment management fees, investment income and dividends and distributions from their subsidiaries. The liquidity requirements of our regulated insurance subsidiaries principally relate to the liabilities associated with their various insurance and investment products, operating costs and expenses, the payment of dividends to us, contributions to their subsidiaries, payments of principal and interest on their outstanding debt obligations and income taxes. Liabilities arising from insurance and investment products include the payment of benefits and claims, as well as cash payments in connection with policy surrenders and withdrawals, policy loans and obligations to redeem funding agreements.
For long-duration coverage products, we generally anticipate a significant amount of claim payments will come due in five or more years from the date of our Annual Report on Form 10-K. In our long-term care insurance business, we expect overall claim costs to continue to increase over time as our blocks age, with peak claim years over a decade away. For information on discounted and undiscounted expected future benefit payments, see note 8 in our consolidated financial statements under “Item 8—Financial Statements and Supplementary Data.” We also expect renewal premiums on the in-force block of our legacy long-term care insurance business to decline over time as the block runs off and as policyholders elect benefit reductions in connection with our in-force rate actions and legal settlements; however, we expect this decline to be partially offset by future approved rate actions. As we manage our legacy U.S. life insurance subsidiaries on a standalone basis, they will continue to rely on their statutory capital, significant reserves, prudent management of the in-force blocks and long-term care insurance in-force rate actions to satisfy policyholder obligations.
Given the challenging macroeconomic environment in 2023 and 2024, employee costs have increased driven in part by wage inflation, the competitive labor market and low labor participation. Additionally, in our long-term care insurance business, we have observed an increase in the cost of care due in part to elevated inflation. These inflationary pressures have not had a significant impact on our liquidity to date; however, if these
115
Table of Contents
conditions persist, they could have a material adverse impact on our liquidity, results of operations and financial condition. We will continue to monitor macroeconomic trends, including inflation, to help mitigate any potential adverse impacts to our liquidity.
Our insurance subsidiaries maintain investment strategies intended to provide adequate funds to pay benefits without forced sales of investments. Products having liabilities with longer durations, such as certain life insurance and long-term care insurance policies, are typically matched with investments having similar duration such as long-term fixed maturity securities and commercial mortgage loans. Shorter-term liabilities are typically matched with fixed maturity securities that have short- and medium-term fixed maturities. In addition, our insurance subsidiaries hold highly liquid, high quality short-term investment securities and other liquid investment grade fixed maturity securities to fund anticipated operating expenses, surrenders and withdrawals. As of December 31, 2024, our total cash, cash equivalents and invested assets were $60.0 billion. Our investments in privately placed fixed maturity securities, commercial mortgage loans, policy loans, bank loans, limited partnership investments and select mortgage-backed and asset-backed securities are relatively illiquid. These asset classes represented approximately 44% of the carrying value of our total cash, cash equivalents and invested assets as of December 31, 2024.
Off-balance sheet commitments
As of December 31, 2024, we were committed to fund $1,761 million in limited partnership investments, $263 million in private placement investments, $140 million of bank loan investments and $2 million in commercial mortgage loan investments.
Genworth Holdings’ guarantees
Genworth Holdings has provided a limited guarantee of up to $175 million, subject to adjustments, to one of its insurance subsidiaries to support its mortgage insurance business in Mexico. In January 2022, Genworth Holdings terminated this limited guarantee in regard to new business. Based on the risk in-force of policies subject to the guarantee, we estimate that Genworth Holdings’ exposure under the guarantee was approximately $145 million as of December 31, 2024. We believe this insurance subsidiary has adequate reserves to cover its underlying obligations.
Genworth Holdings provided an unlimited guarantee for the benefit of policyholders for the payment of valid claims by our European mortgage insurance subsidiary prior to its sale in May 2016. Following the sale of this United Kingdom subsidiary to AmTrust Financial Services, Inc., the guarantee was limited to the payment of valid claims on policies in-force prior to the sale date and those written approximately 90 days subsequent to the date of the sale, and AmTrust Financial Services, Inc. has agreed to provide us with a limited indemnification in the event there is any exposure under the guarantee. As of December 31, 2024, the risk in-force of active policies was approximately $766 million.
Supplemental Condensed Consolidating Financial Information
Genworth Financial provides a full and unconditional guarantee to the trustee and holders of Genworth Holdings’ outstanding senior and subordinated notes (registered securities under the Securities Act of 1933), on an unsecured unsubordinated and subordinated basis, respectively, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, the outstanding senior and subordinated notes and their respective indentures. Genworth Holdings is a direct, 100% owned subsidiary of Genworth Financial.
Excluding investments in subsidiaries, the assets, liabilities and results of operations of Genworth Financial and Genworth Holdings, on a combined basis, are not material to the consolidated financial position or the consolidated results of operations of Genworth. In addition, none of Genworth Financial’s direct or indirect subsidiaries, other than Genworth Holdings, are issuers or guarantors of any guaranteed securities. Therefore, in
116
Table of Contents
accordance with Rule 13-01 of Regulation S-X, we are permitted, and we elected, to exclude the summarized financial information for both the issuer and guarantor of the registered securities.